0000898173--12-312024Q3falseO Reilly Automotive Inc000057838920590727920000898173us-gaap:LineOfCreditMember2024-09-300000898173us-gaap:LineOfCreditMember2023-12-310000898173us-gaap:SubsequentEventMember2024-10-012024-11-080000898173us-gaap:SubsequentEventMember2011-01-012024-11-080000898173us-gaap:CommonStockMember2024-07-012024-09-300000898173us-gaap:CommonStockMember2024-01-012024-09-300000898173us-gaap:CommonStockMember2023-07-012023-09-300000898173us-gaap:CommonStockMember2023-01-012023-09-300000898173us-gaap:RetainedEarningsMember2024-09-300000898173us-gaap:AdditionalPaidInCapitalMember2024-09-300000898173us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300000898173us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300000898173us-gaap:RetainedEarningsMember2024-06-300000898173us-gaap:AdditionalPaidInCapitalMember2024-06-300000898173us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300000898173us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-3000008981732024-06-300000898173us-gaap:RetainedEarningsMember2023-12-310000898173us-gaap:AdditionalPaidInCapitalMember2023-12-310000898173us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000898173us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000898173us-gaap:RetainedEarningsMember2023-09-300000898173us-gaap:AdditionalPaidInCapitalMember2023-09-300000898173us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300000898173us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000898173us-gaap:RetainedEarningsMember2023-06-300000898173us-gaap:AdditionalPaidInCapitalMember2023-06-300000898173us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000898173us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-3000008981732023-06-300000898173us-gaap:RetainedEarningsMember2022-12-310000898173us-gaap:AdditionalPaidInCapitalMember2022-12-310000898173us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000898173us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000898173us-gaap:EmployeeStockOptionMember2023-12-310000898173us-gaap:StockOptionMember2023-01-012023-09-300000898173us-gaap:EmployeeStockOptionMember2024-09-300000898173us-gaap:EmployeeStockOptionMember2023-01-012023-09-300000898173srt:MinimumMemberus-gaap:RestrictedStockMemberorly:EmployeeStockPurchasePlanMember2024-01-012024-09-300000898173srt:MaximumMemberus-gaap:RestrictedStockMemberorly:EmployeeStockPurchasePlanMember2024-01-012024-09-300000898173orly:ProfessionalServiceProviderCustomerMember2024-07-012024-09-300000898173orly:OtherCustomersAndSalesAdjustmentsMember2024-07-012024-09-300000898173orly:DIYCustomerMember2024-07-012024-09-300000898173orly:ProfessionalServiceProviderCustomerMember2024-01-012024-09-300000898173orly:OtherCustomersAndSalesAdjustmentsMember2024-01-012024-09-300000898173orly:DIYCustomerMember2024-01-012024-09-300000898173orly:ProfessionalServiceProviderCustomerMember2023-07-012023-09-300000898173orly:OtherCustomersAndSalesAdjustmentsMember2023-07-012023-09-300000898173orly:DIYCustomerMember2023-07-012023-09-300000898173orly:ProfessionalServiceProviderCustomerMember2023-01-012023-09-300000898173orly:OtherCustomersAndSalesAdjustmentsMember2023-01-012023-09-300000898173orly:DIYCustomerMember2023-01-012023-09-300000898173us-gaap:AccumulatedTranslationAdjustmentMember2024-07-012024-09-300000898173us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000898173us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300000898173us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000898173us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300000898173us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000898173us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300000898173us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000898173us-gaap:RetainedEarningsMember2024-07-012024-09-300000898173us-gaap:RetainedEarningsMember2024-01-012024-09-300000898173us-gaap:RetainedEarningsMember2023-07-012023-09-300000898173us-gaap:RetainedEarningsMember2023-01-012023-09-300000898173us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMember2024-09-300000898173srt:MaximumMemberus-gaap:CommercialPaperMember2024-09-300000898173us-gaap:LineOfCreditMember2024-01-012024-09-300000898173us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-01-012024-09-300000898173us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMemberus-gaap:UnsecuredDebtMember2024-09-300000898173us-gaap:LetterOfCreditMemberus-gaap:UnsecuredDebtMember2024-09-300000898173us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMemberus-gaap:UnsecuredDebtMember2023-12-310000898173us-gaap:LetterOfCreditMemberus-gaap:UnsecuredDebtMember2023-12-310000898173us-gaap:FairValueInputsLevel1Member2024-09-300000898173us-gaap:FairValueInputsLevel1Member2023-12-310000898173orly:GroupeDelVastoMember2024-09-302024-09-300000898173us-gaap:StockOptionMember2024-01-012024-09-300000898173us-gaap:StockOptionMember2024-09-300000898173us-gaap:RestrictedStockMemberorly:EmployeeStockPurchasePlanMember2024-01-012024-09-300000898173us-gaap:EmployeeStockOptionMember2024-01-012024-09-300000898173orly:ProfitSharingAndSavingsPlanEmployeeNextFourPercentOfContributedWagesMemberorly:ProfitSharingAndSavingsPlanMember2024-01-012024-09-300000898173orly:ProfitSharingAndSavingsPlanEmployeeFirstTwoPercentOfContributedWagesMemberorly:ProfitSharingAndSavingsPlanMember2024-01-012024-09-300000898173orly:ProfitSharingAndSavingsPlanMember2024-07-012024-09-300000898173orly:ProfitSharingAndSavingsPlanMember2024-01-012024-09-300000898173orly:ProfitSharingAndSavingsPlanMember2023-07-012023-09-300000898173orly:ProfitSharingAndSavingsPlanMember2023-01-012023-09-300000898173us-gaap:StockAppreciationRightsSARSMember2024-09-300000898173us-gaap:StockAppreciationRightsSARSMember2023-12-310000898173orly:NonqualifiedDeferredCompensationPlanMember2024-09-300000898173orly:NonqualifiedDeferredCompensationPlanMember2023-12-310000898173srt:MaximumMemberorly:NonqualifiedDeferredCompensationPlanMember2024-07-012024-09-300000898173orly:NonqualifiedDeferredCompensationPlanMember2024-01-012024-09-300000898173srt:MaximumMemberorly:NonqualifiedDeferredCompensationPlanMember2023-07-012023-09-300000898173srt:MaximumMemberorly:NonqualifiedDeferredCompensationPlanMember2023-01-012023-09-300000898173orly:SupplierFinanceProgramsMember2024-01-012024-09-300000898173orly:SupplierFinanceProgramsMember2023-01-012023-12-310000898173srt:MinimumMemberus-gaap:SeniorNotesMember2024-09-300000898173srt:MaximumMemberus-gaap:SeniorNotesMember2024-09-300000898173us-gaap:FairValueInputsLevel2Member2024-09-300000898173us-gaap:FairValueInputsLevel2Member2023-12-310000898173orly:SeniorNotesDue2034At5.000Memberus-gaap:SeniorNotesMember2024-09-300000898173orly:SeniorNotesDue2032At4.700Memberus-gaap:SeniorNotesMember2024-09-300000898173orly:SeniorNotesDue2031At1750Memberus-gaap:SeniorNotesMember2024-09-300000898173orly:SeniorNotesDue2030At4200Memberus-gaap:SeniorNotesMember2024-09-300000898173orly:SeniorNotesDue2029At3900Memberus-gaap:SeniorNotesMember2024-09-300000898173orly:SeniorNotesDue2028At4350Memberus-gaap:SeniorNotesMember2024-09-300000898173orly:SeniorNotesDue2027At3600Memberus-gaap:SeniorNotesMember2024-09-300000898173orly:SeniorNotesDue2026At5.750Memberus-gaap:SeniorNotesMember2024-09-300000898173orly:SeniorNotesDue2026At3550Memberus-gaap:SeniorNotesMember2024-09-300000898173us-gaap:CommercialPaperMember2024-09-300000898173orly:SeniorNotesDue2032At4.700Memberus-gaap:SeniorNotesMember2023-12-310000898173orly:SeniorNotesDue2031At1750Memberus-gaap:SeniorNotesMember2023-12-310000898173orly:SeniorNotesDue2030At4200Memberus-gaap:SeniorNotesMember2023-12-310000898173orly:SeniorNotesDue2029At3900Memberus-gaap:SeniorNotesMember2023-12-310000898173orly:SeniorNotesDue2028At4350Memberus-gaap:SeniorNotesMember2023-12-310000898173orly:SeniorNotesDue2027At3600Memberus-gaap:SeniorNotesMember2023-12-310000898173orly:SeniorNotesDue2026At5.750Memberus-gaap:SeniorNotesMember2023-12-310000898173orly:SeniorNotesDue2026At3550Memberus-gaap:SeniorNotesMember2023-12-310000898173us-gaap:CommercialPaperMember2023-12-310000898173us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMemberus-gaap:BaseRateMember2024-01-012024-09-300000898173us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMemberorly:SpreadOverTermBenchmarkRevolvingLoansRateMember2024-01-012024-09-300000898173us-gaap:CommonStockMember2024-09-300000898173us-gaap:CommonStockMember2024-06-300000898173us-gaap:CommonStockMember2023-12-310000898173us-gaap:CommonStockMember2023-09-300000898173us-gaap:CommonStockMember2023-06-300000898173us-gaap:CommonStockMember2022-12-3100008981732023-09-3000008981732022-12-310000898173us-gaap:GoodwillMemberorly:GroupeDelVastoMember2024-09-300000898173us-gaap:EmployeeStockOptionMemberus-gaap:StockOptionMember2024-07-012024-09-300000898173us-gaap:StockAppreciationRightsSARSMember2024-07-012024-09-300000898173us-gaap:RestrictedStockMember2024-07-012024-09-300000898173orly:EmployeeStockPurchasePlanMember2024-07-012024-09-300000898173us-gaap:EmployeeStockOptionMemberus-gaap:StockOptionMember2024-01-012024-09-300000898173us-gaap:RestrictedStockMember2024-01-012024-09-300000898173us-gaap:EmployeeStockOptionMemberus-gaap:StockOptionMember2023-07-012023-09-300000898173us-gaap:StockAppreciationRightsSARSMember2023-07-012023-09-300000898173us-gaap:RestrictedStockMember2023-07-012023-09-300000898173orly:EmployeeStockPurchasePlanMember2023-07-012023-09-300000898173us-gaap:EmployeeStockOptionMemberus-gaap:StockOptionMember2023-01-012023-09-300000898173us-gaap:StockAppreciationRightsSARSMember2023-01-012023-09-300000898173us-gaap:RestrictedStockMember2023-01-012023-09-300000898173orly:EmployeeStockPurchasePlanMember2023-01-012023-09-300000898173us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300000898173us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300000898173us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300000898173us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300000898173orly:SupplierFinanceProgramsMember2024-09-300000898173orly:SupplierFinanceProgramsMember2023-12-3100008981732023-11-1600008981732023-11-162023-11-1600008981732023-05-232023-05-2300008981732023-07-012023-09-3000008981732023-01-012023-09-300000898173us-gaap:StockAppreciationRightsSARSMember2024-01-012024-09-300000898173us-gaap:SeniorNotesMember2024-09-300000898173orly:GroupeDelVastoMember2024-01-220000898173orly:SeniorNotesDue2034At5.000Memberus-gaap:SeniorNotesMember2024-08-192024-08-190000898173us-gaap:SeniorNotesMember2024-01-012024-09-300000898173us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMemberus-gaap:UnsecuredDebtMember2024-01-012024-09-300000898173us-gaap:LineOfCreditMemberorly:SwingLineRevolverMemberus-gaap:UnsecuredDebtMember2024-01-012024-09-300000898173us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMember2024-01-012024-09-300000898173orly:EmployeeStockPurchasePlanMember2024-01-012024-09-300000898173orly:SeniorNotesDue2034At5.000Memberus-gaap:SeniorNotesMember2024-08-190000898173srt:MinimumMemberus-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMember2024-01-012024-09-300000898173srt:MaximumMemberus-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMember2024-01-012024-09-3000008981732024-09-3000008981732023-12-3100008981732024-07-012024-09-3000008981732024-11-0400008981732024-01-012024-09-30xbrli:sharesiso4217:USDxbrli:pureorly:Dorly:itemorly:entityiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

​

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024

OR

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

​

Graphic

O’REILLY AUTOMOTIVE, INC.

(Exact name of registrant as specified in its charter)

​

Missouri

    

000-21318

    

27-4358837

(State or other jurisdiction of

​

Commission file number

​

(I.R.S. Employer Identification No.)

incorporation or organization)

​

​

​

​

​

233 South Patterson Avenue

Springfield, Missouri 65802

(Address of principal executive offices, Zip code)

(417) 862-6708

(Registrant’s telephone number, including area code)

Not applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

​

​

​

​

​

Title of Each Class

    

Trading Symbol(s)

    

Name of Each Exchange on which Registered

Common Stock,

$0.01 par value

​

ORLY

​

The Nasdaq Stock Market LLC

​

​

​

​

(Nasdaq Global Select Market)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒   No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☒   No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

​

​

​

​

​

Large accelerated filer

☒

Accelerated filer

☐

Emerging growth company

☐

Non-accelerated filer

☐

Smaller reporting company

☐

​

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐   No  ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date:  Common stock, $0.01 par value - 57,730,693 shares outstanding as of November 4, 2024.  

​

​

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2024

TABLE OF CONTENTS

​

​

    

Page

PART I - FINANCIAL INFORMATION

​

2

ITEM 1 - FINANCIAL STATEMENTS (UNAUDITED)

​

2

Condensed Consolidated Balance Sheets

​

2

Condensed Consolidated Statements of Income

​

3

Condensed Consolidated Statements of Comprehensive Income

​

4

Condensed Consolidated Statements of Shareholders’ Equity (Deficit)

​

5

Condensed Consolidated Statements of Cash Flows

​

6

Notes to Condensed Consolidated Financial Statements

​

7

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

​

18

ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

​

24

ITEM 4 - CONTROLS AND PROCEDURES

​

25

PART II - OTHER INFORMATION

​

26

ITEM 1 - LEGAL PROCEEDINGS

​

26

ITEM 1A - RISK FACTORS

​

26

ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

​

26

ITEM 5 - OTHER INFORMATION

​

26

ITEM 6 - EXHIBITS

​

27

SIGNATURE PAGES

​

28

​

​

1

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

​

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

​

​

​

​

​

​

​

​

​

    

September 30, 2024

    

December 31, 2023

​

​

(Unaudited)

​

(Note)

Assets

 

​

  

 

​

  

Current assets:

 

​

  

 

​

  

Cash and cash equivalents

​

$

115,613

​

$

279,132

Accounts receivable, net

​

 

401,950

​

 

375,049

Amounts receivable from suppliers

​

 

154,300

​

 

140,443

Inventory

​

 

4,913,237

​

 

4,658,367

Other current assets

​

 

113,187

​

 

105,311

Total current assets

​

 

5,698,287

​

 

5,558,302

​

​

​

​

​

​

​

Property and equipment, at cost

​

 

8,969,137

​

 

8,312,367

Less: accumulated depreciation and amortization

​

 

3,532,755

​

 

3,275,387

Net property and equipment

​

 

5,436,382

​

 

5,036,980

​

​

​

​

​

​

​

Operating lease, right-of-use assets

​

​

2,269,929

​

​

2,200,554

Goodwill

​

 

997,226

​

 

897,696

Other assets, net

​

 

175,698

​

 

179,463

Total assets

​

$

14,577,522

​

$

13,872,995

​

​

​

​

​

​

​

Liabilities and shareholders’ deficit

​

 

  

​

 

  

Current liabilities:

​

 

  

​

 

  

Accounts payable

​

$

6,359,619

​

$

6,091,700

Self-insurance reserves

​

 

123,505

​

 

128,548

Accrued payroll

​

 

141,361

​

 

138,122

Accrued benefits and withholdings

​

 

201,351

​

 

174,650

Income taxes payable

​

 

206,776

​

 

7,860

Current portion of operating lease liabilities

​

​

408,571

​

​

389,536

Other current liabilities

​

 

743,982

​

 

730,937

Total current liabilities

​

 

8,185,165

​

 

7,661,353

​

​

​

​

​

​

​

Long-term debt

​

 

5,359,810

​

 

5,570,125

Operating lease liabilities, less current portion

​

​

1,938,162

​

​

1,881,344

Deferred income taxes

​

 

325,869

​

 

295,471

Other liabilities

​

 

207,580

​

 

203,980

​

​

​

​

​

​

​

Shareholders’ equity (deficit):

​

 

  

​

 

  

Common stock, $0.01 par value:

​

 

​

​

​

​

Authorized shares – 245,000,000

​

​

​

​

​

​

Issued and outstanding shares –

​

​

​

​

​

​

57,838,920 as of September 30, 2024, and

​

​

​

​

​

​

59,072,792 as of December 31, 2023

​

​

578

​

 

591

Additional paid-in capital

​

 

1,449,447

​

 

1,352,275

Retained deficit

​

 

(2,875,955)

​

 

(3,131,532)

Accumulated other comprehensive (loss) income

​

​

(13,134)

​

​

39,388

Total shareholders’ deficit

​

 

(1,439,064)

​

 

(1,739,278)

​

​

​

​

​

​

​

Total liabilities and shareholders’ deficit

​

$

14,577,522

​

$

13,872,995

​

Note:  The balance sheet at December 31, 2023, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by United States generally accepted accounting principles for complete financial statements.

See accompanying Notes to condensed consolidated financial statements.

​

2

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In thousands, except per share data)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Sales

​

$

4,364,437

​

$

4,203,380

​

$

12,612,878

​

$

11,980,235

Cost of goods sold, including warehouse and distribution expenses

​

 

2,113,212

​

 

2,042,917

​

 

6,159,421

​

 

5,842,861

Gross profit

​

 

2,251,225

​

 

2,160,463

​

 

6,453,457

​

 

6,137,374

​

​

​

​

​

​

​

​

​

​

​

​

​

Selling, general and administrative expenses

​

 

1,354,497

​

 

1,263,241

​

 

3,940,950

​

 

3,669,734

Operating income

​

 

896,728

​

 

897,222

​

 

2,512,507

​

 

2,467,640

​

​

​

​

​

​

​

​

​

​

​

​

​

Other income (expense):

​

 

  

​

 

  

​

 

  

​

 

  

Interest expense

​

 

(55,166)

​

 

(51,361)

​

 

(167,145)

​

 

(145,520)

Interest income

​

 

2,055

​

 

1,292

​

 

5,239

​

 

2,920

Other, net

​

 

4,304

​

 

(486)

​

 

9,266

​

 

8,179

Total other expense

​

 

(48,807)

​

 

(50,555)

​

 

(152,640)

​

 

(134,421)

​

​

​

​

​

​

​

​

​

​

​

​

​

Income before income taxes

​

 

847,921

​

 

846,667

​

 

2,359,867

​

 

2,333,219

Provision for income taxes

​

 

182,457

​

 

196,840

​

 

524,317

​

 

539,142

Net income

​

$

665,464

​

$

649,827

​

$

1,835,550

​

$

1,794,077

​

​

​

​

​

​

​

​

​

​

​

​

​

Earnings per share-basic:

​

 

  

​

 

  

​

 

  

​

 

  

Earnings per share

​

$

11.47

​

$

10.82

​

$

31.34

​

$

29.46

Weighted-average common shares outstanding – basic

​

 

57,998

​

 

60,082

​

 

58,563

​

 

60,905

​

​

​

​

​

​

​

​

​

​

​

​

​

Earnings per share-assuming dilution:

​

 

  

​

 

  

​

 

  

​

 

  

Earnings per share

​

$

11.41

​

$

10.72

​

$

31.14

​

$

29.20

Weighted-average common shares outstanding – assuming dilution

​

 

58,335

​

 

60,590

​

 

58,942

​

 

61,445

​

See accompanying Notes to condensed consolidated financial statements.

​

​

3

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(In thousands)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Net income

​

$

665,464

​

$

649,827

​

$

1,835,550

​

$

1,794,077

Other comprehensive income (loss):

​

​

​

​

​

​

​

​

​

​

​

​

Foreign currency translation adjustments

​

 

(22,026)

​

 

(5,782)

​

 

(52,522)

​

 

27,293

Total other comprehensive (loss) income

​

​

(22,026)

​

​

(5,782)

​

​

(52,522)

​

​

27,293

​

​

 

​

​

​

​

​

​

​

​

​

​

Comprehensive income

​

$

643,438

​

$

644,045

​

$

1,783,028

​

$

1,821,370

​

See accompanying Notes to condensed consolidated financial statements.

​

​

​

4

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

(In thousands)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended September 30, 2024

​

 

​

​

​

​

 

​

​

 

​

​

​

Accumulated

 

​

​

​

​

​

​

​

​

​

Additional

​

​

​

​

Other

​

​

​

​

​

Common Stock

​

Paid-In

​

Retained

​

Comprehensive

​

​

​

​

    

Shares

    

Par Value

    

Capital

    

Deficit

​

Income (Loss)

    

Total

Balance at June 30, 2024

 

58,239

​

$

582

​

$

1,415,799

​

$

(3,008,665)

​

$

8,892

​

$

(1,583,392)

Net income

 

—

​

 

—

​

 

—

​

 

665,464

​

​

—

​

 

665,464

Total other comprehensive loss

​

—

​

​

—

​

​

—

​

​

—

​

​

(22,026)

​

​

(22,026)

Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes

 

6

​

 

—

​

 

5,809

​

 

—

​

​

—

​

 

5,809

Net issuance of common stock upon exercise of stock options

 

92

​

 

1

​

 

33,225

​

 

—

​

​

—

​

 

33,226

Share based compensation

 

—

​

 

—

​

 

6,865

​

 

—

​

​

—

​

 

6,865

Share repurchases, including fees

 

(498)

​

 

(5)

​

 

(12,251)

​

 

(528,462)

​

​

—

​

 

(540,718)

Excise tax on share repurchases

 

—

​

 

—

​

 

—

​

 

(4,292)

​

​

—

​

 

(4,292)

Balance at September 30, 2024

 

57,839

​

$

578

​

$

1,449,447

​

$

(2,875,955)

​

$

(13,134)

​

$

(1,439,064)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Nine Months Ended September 30, 2024

​

 

​

​

​

​

 

​

 

​

​

​

Accumulated

 

​

​

​

​

​

​

​

​

​

Additional

​

​

​

​

Other

​

​

​

​

​

Common Stock

​

Paid-In

​

Retained

​

Comprehensive

​

​

​

​

    

Shares

    

Par Value

    

Capital

    

Deficit

​

Income (Loss)

    

Total

Balance at December 31, 2023

 

59,073

​

$

591

​

$

1,352,275

​

$

(3,131,532)

​

$

39,388

​

$

(1,739,278)

Net income

 

—

​

 

—

​

 

—

​

 

1,835,550

​

​

—

​

 

1,835,550

Total other comprehensive loss

​

—

​

​

—

​

​

—

​

​

—

​

​

(52,522)

​

​

(52,522)

Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes

 

20

​

 

—

​

 

18,213

​

 

—

​

​

—

​

 

18,213

Net issuance of common stock upon exercise of stock options

 

291

​

 

3

​

 

96,043

​

 

—

​

​

—

​

 

96,046

Share-based compensation

 

—

​

 

—

​

 

20,138

​

 

—

​

​

—

​

 

20,138

Share repurchases, including fees

​

(1,545)

​

​

(16)

​

​

(37,222)

​

​

(1,567,271)

​

​

—

​

​

(1,604,509)

Excise tax on share repurchases

 

—

​

 

—

​

 

—

​

 

(12,702)

​

​

—

​

 

(12,702)

Balance at September 30, 2024

 

57,839

​

$

578

​

$

1,449,447

​

$

(2,875,955)

​

$

(13,134)

​

$

(1,439,064)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended September 30, 2023

​

 

​

​

​

​

 

​

 

​

​

​

Accumulated

 

​

​

​

​

​

​

​

​

​

Additional

​

​

​

​

Other

​

​

​

​

​

Common Stock

​

Paid-In

​

Retained

​

Comprehensive

​

​

​

​

    

Shares

    

Par Value

    

Capital

    

Deficit

​

Income

    

Total

Balance at June 30, 2023

 

60,402

​

$

604

​

$

1,330,270

​

$

(2,994,418)

​

$

36,071

​

$

(1,627,473)

Net income

 

—

​

 

—

​

 

—

​

 

649,827

​

​

—

​

 

649,827

Total other comprehensive loss

​

—

​

​

—

​

​

—

​

​

—

​

​

(5,782)

​

​

(5,782)

Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes

 

7

​

 

—

​

 

5,239

​

 

—

​

​

—

​

 

5,239

Net issuance of common stock upon exercise of stock options

 

64

​

 

1

​

 

17,685

​

 

—

​

​

—

​

 

17,686

Share based compensation

 

—

​

 

—

​

 

6,900

​

 

—

​

​

—

​

 

6,900

Share repurchases, including fees

 

(852)

​

 

(9)

​

 

(18,931)

​

 

(780,589)

​

​

—

​

 

(799,529)

Excise tax on share repurchases

​

—

​

​

—

​

​

—

​

​

(7,337)

​

​

—

​

​

(7,337)

Balance at September 30, 2023

 

59,621

​

$

596

​

$

1,341,163

​

$

(3,132,517)

​

$

30,289

​

$

(1,760,469)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Nine Months Ended September 30, 2023

​

 

​

​

​

​

 

​

 

​

​

​

Accumulated

 

​

​

​

​

​

​

​

​

​

Additional

​

​

​

​

Other

​

​

​

​

​

Common Stock

​

Paid-In

​

Retained

​

Comprehensive

​

​

​

​

    

Shares

    

Par Value

    

Capital

    

Deficit

​

Income

    

Total

Balance at December 31, 2022

 

62,353

​

$

624

​

$

1,311,488

​

$

(2,375,860)

​

$

2,996

​

$

(1,060,752)

Net income

 

—

​

 

—

​

 

—

​

 

1,794,077

​

​

—

​

 

1,794,077

Total other comprehensive income

​

—

​

​

—

​

​

—

​

​

—

​

​

27,293

​

​

27,293

Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes

 

22

​

 

—

​

 

16,649

​

 

—

​

​

—

​

 

16,649

Net issuance of common stock upon exercise of stock options

 

207

​

 

2

​

 

56,483

​

 

—

​

​

—

​

 

56,485

Share-based compensation

 

—

​

 

—

​

 

20,555

​

 

—

​

​

—

​

 

20,555

Share repurchases, including fees

 

(2,961)

​

 

(30)

​

 

(64,012)

​

 

(2,526,938)

​

​

—

​

 

(2,590,980)

Excise tax on share repurchases

​

—

​

​

—

​

​

—

​

​

(23,796)

​

​

—

​

​

(23,796)

Balance at September 30, 2023

 

59,621

​

$

596

​

$

1,341,163

​

$

(3,132,517)

​

$

30,289

​

$

(1,760,469)

See accompanying Notes to condensed consolidated financial statements.

5

​

​

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

​

​

​

​

​

​

​

​

​

​

For the Nine Months Ended

​

​

September 30, 

​

    

2024

    

2023

Operating activities:

 

​

  

 

​

  

Net income

​

$

1,835,550

​

$

1,794,077

Adjustments to reconcile net income to net cash provided by operating activities:

​

 

  

​

 

​

Depreciation and amortization of property, equipment and intangibles

​

 

339,324

​

 

296,583

Amortization of debt discount and issuance costs

​

 

4,870

​

 

3,597

Deferred income taxes

​

 

8,536

​

 

35,982

Share-based compensation programs

​

 

21,600

​

 

21,948

Other

​

 

5,928

​

 

3,574

Changes in operating assets and liabilities:

​

 

​

​

 

​

Accounts receivable

​

 

(9,175)

​

 

(58,658)

Inventory

​

 

(212,491)

​

 

(263,896)

Accounts payable

​

 

252,454

​

 

315,910

Income taxes payable

​

 

198,780

​

 

353,366

Other

​

 

(20,287)

​

 

15,172

Net cash provided by operating activities

​

 

2,425,089

​

 

2,517,655

​

​

​

​

​

​

​

Investing activities:

​

 

  

​

 

  

Purchases of property and equipment

​

 

(732,916)

​

 

(753,958)

Proceeds from sale of property and equipment

​

 

10,268

​

 

10,461

Investment in tax credit equity investments

​

​

—

​

​

(4,150)

Other, including acquisitions, net of cash acquired

​

 

(160,960)

​

 

(2,126)

Net cash used in investing activities

​

 

(883,608)

​

 

(749,773)

​

​

​

​

​

​

​

Financing activities:

​

 

  

​

 

  

Proceeds from borrowings on revolving credit facility

​

 

30,000

​

 

3,227,000

Payments on revolving credit facility

​

 

(30,000)

​

 

(3,227,000)

Net (payments) proceeds of commercial paper

​

​

(706,850)

​

​

1,025,075

Proceeds from the issuance of long-term debt

​

 

498,910

​

 

—

Principal payments on long-term debt

​

​

—

​

​

(300,000)

Payment of debt issuance costs

​

 

(3,900)

​

 

(39)

Repurchases of common stock

​

 

(1,604,509)

​

 

(2,590,980)

Net proceeds from issuance of common stock

​

 

112,825

​

 

71,604

Other

​

 

(569)

​

 

(354)

Net cash used in financing activities

​

 

(1,704,093)

​

 

(1,794,694)

​

​

​

​

​

​

​

Effect of exchange rate changes on cash

​

​

(907)

​

​

893

Net decrease in cash and cash equivalents

​

 

(163,519)

​

 

(25,919)

Cash and cash equivalents at beginning of the period

​

 

279,132

​

 

108,583

Cash and cash equivalents at end of the period

​

$

115,613

​

$

82,664

​

​

​

​

​

​

​

Supplemental disclosures of cash flow information:

​

 

  

​

 

  

Income taxes paid

​

$

419,331

​

$

147,128

Interest paid, net of capitalized interest

​

 

139,228

​

 

127,085

​

See accompanying Notes to condensed consolidated financial statements.

​

​

​

6

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

September 30, 2024

​

NOTE 1 – BASIS OF PRESENTATION

​

The accompanying unaudited condensed consolidated financial statements of O’Reilly Automotive, Inc. and its subsidiaries (the “Company” or “O’Reilly”) have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.  Operating results for the three and nine months ended September 30, 2024, are not necessarily indicative of the results that may be expected for the year ended December 31, 2024.  For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2023.

​

Principles of consolidation:

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All inter-company balances and transactions have been eliminated in consolidation.    

​

NOTE 2 – BUSINESS COMBINATION

​

On January 22, 2024, the Company completed the previously announced strategic acquisition of Groupe Del Vasto (“Vast Auto”), an auto parts supplier headquartered in Montreal, Quebec, Canada, pursuant to a stock purchase agreement whereby 100% of all outstanding shares of Vast Auto were acquired, with all consideration paid in cash at closing.  The acquisition of Vast Auto represents O’Reilly’s entrance into the Canadian automotive aftermarket.  At the time of the acquisition, Vast Auto operated two distribution centers and six satellite warehouses that support a network of 23 company-owned stores and thousands of independent jobber and professional customers across Eastern Canada.  The results of Vast Auto’s operations have been included in the Company’s condensed consolidated financial statements beginning from the date of acquisition.  Pro forma results of operations related to the acquisition of Vast Auto are not presented as Vast Auto’s results are not material to the Company’s results of operations.

​

The purchase price allocation process, which is still ongoing, consists of collecting data and information to enable the Company to value the assets acquired and liabilities assumed as a result of the business combination.  The Company has substantially completed purchase price allocations related to working capital, including inventory, accounts receivable, accounts payable, and property, plant, and equipment.  Potential identifiable intangible assets that continue to be evaluated include, but are not limited to, trade names and trademarks, non-compete agreements, and customer relationships.  In addition, other assets, including internal use software, and other assumed liabilities may be identified, valued, and recorded.  The Company has engaged a third-party valuation specialist to assist with the valuation of the intangible assets.  This process is ongoing and the Company remains in the initial measurement period.

​

The preliminary purchase price allocation remains provisional and will change as additional information is obtained and valuation work is completed during the initial measurement period.  The Company’s preliminary assessment resulted in the initial recognition of $109.8 million of goodwill and intangible assets, which has been increased by $0.4 million during the initial measurement period, including impacts from the recognition of applicable deferred taxes related to the acquisition, which is included in “Goodwill” on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024.  Goodwill generated from this acquisition is not amortizable for tax purposes.

​

NOTE 3 – VARIABLE INTEREST ENTITIES

​

The Company has invested in certain tax credit funds that promote renewable energy.  These investments generate a return primarily through the realization of federal tax credits and other tax benefits.  The Company accounts for the tax attributes of its renewable energy investments using the deferral method.  Under this method, realized investment tax credits and other tax benefits are recognized as a reduction of the renewable energy tax credits.

​

The Company has determined its investment in these tax credit funds were investments in variable interest entities (“VIEs”).  The Company analyzes any investments in VIEs at inception and again if certain triggering events are identified to determine if it is the primary beneficiary.  The Company considers a variety of factors in identifying the entity that holds the power to direct matters that most significantly impact the VIEs’ economic performance including, but not limited to, the ability to direct financing, leasing, construction, and other operating decisions and activities.  As of September 30, 2024, the Company had invested in six unconsolidated tax credit fund entities that were considered to be VIEs and concluded it was not the primary beneficiary of any of the entities, as it did

7

not have the power to control the activities that most significantly impact the entities, and has therefore accounted for these investments using the equity method.  

​

The Company’s maximum exposure to losses associated with these VIEs is generally limited to its net investment, which was $28.4 million as of September 30, 2024, and was included in “Other assets, net” on the accompanying Condensed Consolidated Balance Sheets.  

​

NOTE 4 – FAIR VALUE MEASUREMENTS

​

The Company uses the fair value hierarchy, which prioritizes the inputs used to measure the fair value of certain of its financial instruments.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  The Company uses the income and market approaches to determine the fair value of its assets and liabilities.  The three levels of the fair value hierarchy are set forth below:

●Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.
●Level 2 – Inputs other than quoted prices in active markets included within Level 1 that are observable for the asset or liability, either directly or indirectly.
●Level 3 – Unobservable inputs for the asset or liability.

​

Financial assets and liabilities measured at fair value on a recurring basis:

The Company invests in various marketable securities with the intention of selling these securities to fulfill its future unsecured obligations under the Company’s nonqualified deferred compensation plan.  See Note 12 for further information concerning the Company’s benefit plans.

​

The Company’s marketable securities were accounted for as trading securities and the carrying amount of its marketable securities were included in “Other assets, net” on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024, and December 31, 2023.  The Company recorded an increase in fair value related to its marketable securities in the amount of $3.3 million and a decrease in fair value related to its marketable securities in the amount of $1.4 million for the three months ended September 30, 2024 and 2023, respectively, which were included in “Other income (expense)” on the accompanying Condensed Consolidated Statements of Income.  The Company recorded an increase in fair value related to its marketable securities in the amount of $7.4 million and $3.6 million for the nine months ended September 30, 2024 and 2023, respectively, which were included in “Other income (expense)” on the accompanying Condensed Consolidated Statements of Income.

​

The tables below identify the estimated fair value of the Company’s marketable securities, determined by reference to quoted market prices (Level 1), as of September 30, 2024, and December 31, 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 30, 2024

​

​

Quoted Priced in Active Markets

​

Significant Other

​

Significant

​

​

​

​

​

for Identical Instruments

​

Observable Inputs

​

Unobservable Inputs

​

​

​

​

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Total

Marketable securities

​

$

65,677

​

$

—

​

$

—

​

$

65,677

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2023

​

​

Quoted Prices in Active Markets

​

Significant Other

​

Significant

​

​

​

​

for Identical Instruments

​

Observable Inputs

​

Unobservable Inputs

​

​

​

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Total

Marketable securities

​

$

59,508

​

$

—

​

$

—

​

$

59,508

​

Non-financial assets and liabilities measured at fair value on a nonrecurring basis:

Certain long-lived non-financial assets and liabilities may be required to be measured at fair value on a nonrecurring basis in certain circumstances, including when there is evidence of impairment.  These non-financial assets and liabilities may include assets acquired in a business combination or property and equipment that are determined to be impaired.  As of September 30, 2024, and December 31, 2023, the Company did not have any non-financial assets or liabilities that had been measured at fair value subsequent to initial recognition.

​

8

Fair value of financial instruments:

The carrying amounts of the Company’s senior notes, unsecured revolving credit facility borrowings, and commercial paper program borrowings are included in “Long-term debt” on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024, and December 31, 2023.  

​

The table below identifies the estimated fair value of the Company’s senior notes, using the market approach.  The fair value as of September 30, 2024, and December 31, 2023, was determined by reference to quoted market prices of the same or similar instruments (Level 2) (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 30, 2024

​

December 31, 2023

​

​

Carrying Amount

​

Estimated Fair Value

​

Carrying Amount

​

Estimated Fair Value

Senior Notes

​

$

5,319,844

​

$

5,268,906

​

$

4,820,543

​

$

4,687,065

​

The carrying amount of the Company’s unsecured revolving credit facility approximates fair value (Level 2), as borrowings under the facility bear variable interest at current market rates.  The carrying amount of the Company’s commercial paper program approximates fair value (Level 2), as borrowings under the program bear interest at market rates prevailing at the time of issuance.  See Note 7 for further information concerning the Company’s senior notes, unsecured revolving credit facility, and commercial paper program.

​

The accompanying Condensed Consolidated Balance Sheets include other financial instruments, including cash and cash equivalents, accounts receivable, amounts receivable from suppliers, and accounts payable.  Due to the short-term nature of these financial instruments, the Company believes that the carrying values of these instruments approximate their fair values.

​

NOTE 5 – LEASES

​

The Company leases certain office space, retail stores, distribution centers, and equipment under long-term, non-cancelable operating leases.  The following table summarizes Total lease cost for the three and nine months ended September 30, 2024 and 2023, which were primarily included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

​

2023

    

2024

​

2023

Operating lease cost

​

$

107,146

​

$

100,559

​

$

315,741

​

$

296,624

Short-term operating lease cost

​

 

1,965

​

 

1,708

​

 

6,375

​

 

7,213

Variable operating lease cost

​

 

29,386

​

 

25,696

​

 

84,565

​

 

75,257

Sublease income

​

 

(1,315)

​

 

(1,143)

​

 

(3,681)

​

 

(3,632)

Total lease cost

​

$

137,182

​

$

126,820

​

$

403,000

​

$

375,462

​

The following table summarizes other lease-related information for the nine months ended September 30, 2024 and 2023:

​

​

​

​

​

​

​

​

​

​

    

For the Nine Months Ended

​

​

September 30, 

​

​

2024

​

2023

Cash paid for amounts included in the measurement of operating lease liabilities:

 

​

  

​

​

​

​

Operating cash flows from operating leases

​

$

309,572

​

$

291,033

Right-of-use assets obtained in exchange for new operating lease liabilities

​

​

291,486

​

​

324,893

​

​

NOTE 6 – SUPPLIER FINANCE PROGRAM

​

The Company has established and maintains supplier finance programs with certain third-party financial institutions, which allow participating merchandise suppliers to voluntarily elect to assign the Company’s payment obligations due to these merchandise suppliers to one of the designated third-party institutions.  Under these supplier finance programs, the Company has agreed to pay the third-party financial institutions the stated amount of confirmed merchandise supplier invoices on the original maturity dates of the invoices, which are generally for a term of one year.  The Company does not have any assets pledged as security or other forms of guarantees for the committed payment to the third-party financial institutions.  As of September 30, 2024, and December 31, 2023, the Company had obligations outstanding under these programs for invoices that were confirmed as valid to the third-party financial institutions in the amounts of $4.5 billion and $4.4 billion, respectively, which were included as a component of “Accounts payable” on the accompanying Condensed Consolidated Balance Sheets.

​

9

NOTE 7 – FINANCING

​

The following table identifies the amounts included in “Long-term debt” on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024, and December 31, 2023 (in thousands):

​

​

​

​

​

​

​

​

​

    

September 30, 2024

    

December 31, 2023

Commercial paper program, weighted-average variable interest rate of 4.980% as of September 30, 2024 and 5.640% as of December 31, 2023

​

​

40,000

​

​

750,900

3.550% Senior Notes due 2026, effective interest rate of 3.570%

​

 

500,000

​

 

500,000

5.750% Senior Notes due 2026, effective interest rate of 5.767%

​

​

750,000

​

​

750,000

3.600% Senior Notes due 2027, effective interest rate of 3.619%

​

 

750,000

​

 

750,000

4.350% Senior Notes due 2028, effective interest rate of 4.383%

​

 

500,000

​

 

500,000

3.900% Senior Notes due 2029, effective interest rate of 3.901%

​

​

500,000

​

​

500,000

4.200% Senior Notes due 2030, effective interest rate of 4.205%

​

​

500,000

​

​

500,000

1.750% Senior Notes due 2031, effective interest rate of 1.798%

​

​

500,000

​

​

500,000

4.700% Senior Notes due 2032, effective interest rate of 4.740%

​

​

850,000

​

​

850,000

5.000% Senior Notes due 2034, effective interest rate of 5.028%

​

​

500,000

​

​

—

Total principal amount of debt

​

​

5,390,000

​

​

5,600,900

Less: Unamortized discount and debt issuance costs

​

​

30,190

​

​

30,775

Total long-term debt

​

$

5,359,810

​

$

5,570,125

​

Unsecured revolving credit facility:

The Company is party to a credit agreement dated June 15, 2021, as amended as of March 6, 2023 (the “Credit Agreement”).  The Credit Agreement provides for a five-year $1.8 billion unsecured revolving credit facility (the “Revolving Credit Facility”) arranged by JPMorgan Chase Bank, N.A., which is scheduled to mature in June of 2026.  The Credit Agreement includes a $200 million sub-limit for the issuance of letters of credit and a $75 million sub-limit for swing line borrowings under the Revolving Credit Facility.  As described in the Credit Agreement governing the Revolving Credit Facility, the Company may, from time to time, subject to certain conditions, increase the aggregate commitments under the Revolving Credit Facility by up to $900 million, provided that the aggregate amount of the commitments does not exceed $2.7 billion at any time.

​

As of September 30, 2024, and December 31, 2023, the Company had outstanding letters of credit, primarily to support obligations related to workers’ compensation, general liability, and other insurance policies, under the Credit Agreement each in the amount of $5.4 million, reducing the aggregate availability under the Credit Agreement by those amounts.  Substantially all of these outstanding letters of credit have a one-year term from the date of issuance.  As of September 30, 2024, and December 31, 2023, the Company had no outstanding borrowings under its Revolving Credit Facility.  

​

Borrowings under the Revolving Credit Facility (other than swing line loans) bear interest, at the Company’s option, at either an Alternate Base Rate or an Adjusted Term SOFR Rate (both as defined in the Credit Agreement) plus an applicable margin.  Swing line loans made under the Revolving Credit Facility bear interest at an Alternate Base Rate plus the applicable margin for Alternate Base Rate loans.  In addition, the Company pays a facility fee on the aggregate amount of the commitments under the Credit Agreement in an amount equal to a percentage of such commitments.  The interest rate margins and facility fee are based upon the better of the ratings assigned to the Company’s debt by Moody’s Investor Service, Inc. and Standard & Poor’s Ratings Services, subject to limited exceptions.  As of September 30, 2024, based upon the Company’s current credit ratings, its margin for Alternate Base Rate loans was 0.000%, its margin for Term Benchmark Revolving Loans was 0.900%, and its facility fee was 0.100%.

​

The Credit Agreement contains certain covenants, including limitations on subsidiary indebtedness, a minimum consolidated fixed charge coverage ratio of 2.50:1.00 and a maximum consolidated leverage ratio of 3.50:1.00.  The consolidated fixed charge coverage ratio includes a calculation of earnings before interest, taxes, depreciation, amortization, rent, and non-cash share-based compensation expense to fixed charges.  Fixed charges include interest expense, capitalized interest, and rent expense.  The consolidated leverage ratio includes a calculation of adjusted debt to earnings before interest, taxes, depreciation, amortization, rent, and non-cash share-based compensation expense.  Adjusted debt includes outstanding debt, outstanding stand-by letters of credit, and similar instruments, five-times rent expense and excludes any premium or discount recorded in conjunction with the issuance of long-term debt.  In the event that the Company should default on any covenant (subject to customary grace periods, cure rights, and materiality thresholds) contained in the Credit Agreement, certain actions may be taken, including, but not limited to, possible termination of commitments, immediate payment of outstanding principal amounts plus accrued interest and other amounts payable under the Credit Agreement, and litigation from lenders.  As of September 30, 2024, the Company remained in compliance with all covenants under the Credit Agreement.

​

In addition to the letters of credit issued under the Credit Agreement described above, as of September 30, 2024, and December 31, 2023, the Company had additional outstanding letters of credit, primarily to support obligations under workers’ compensation, general liability,

10

and other insurance policies, in the amount of $121.9 million and $106.8 million, respectively.  Substantially all of these letters of credit have a one-year term from the date of issuance and were not issued under the Company’s Credit Agreement or another committed facility.

​

Commercial paper program:

On August 9, 2023, the Company established a commercial paper program (the “Program”) pursuant to which it may issue short-term, unsecured commercial paper notes (the “Notes”) under the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.  Amounts available under the Program may be borrowed, repaid, and re-borrowed from time to time, with the aggregate face or principal amount of the Notes outstanding under the Program at any time not to exceed $1.8 billion.  The Notes will have maturities of up to 397 days from the date of issue.  The Notes rank at least pari passu with all of the Company’s other unsecured and unsubordinated indebtedness.  The Company plans to use its Revolving Credit Facility as a liquidity backstop for the repayment of Notes outstanding under the Program.  The Notes issued under the Program were included in “Long-term debt” on the accompanying Condensed Consolidated Balance Sheet as of September 30, 2024, as the Company has the ability and intent to refinance these Notes on a long-term basis.

​

Senior notes:

On August 19, 2024, the Company issued $500 million aggregate principal amount of unsecured 5.000% Senior Notes due 2034 (“5.000% Senior Notes due 2034”) at a price to the public of 99.782% of their face value with U.S. Bank Trust Company, National Association (“U.S. Bank”) as trustee.  Interest on the 5.000% Senior Notes due 2034 is payable on August 19 and February 19 of each year, beginning on February 19, 2025, and is computed on the basis of a 360-day year.

​

As of September 30, 2024, the Company has issued and outstanding a cumulative $5.4 billion aggregate principal amount of unsecured senior notes, which are due between 2026 and 2034, with UMB Bank, N.A. and U.S. Bank Trust Company, National Association as trustees.  Interest on the senior notes, ranging from 1.750% to 5.750%, is payable semi-annually and is computed on the basis of a 360-day year.  None of the Company’s subsidiaries is a guarantor under the senior notes.  Each of the senior notes is subject to certain customary covenants, with which the Company complied as of September 30, 2024.        

​

NOTE 8 – WARRANTIES

​

The Company provides warranties on certain merchandise it sells with warranty periods ranging from 30 days to limited lifetime warranties. The risk of loss arising from warranty claims is typically the obligation of the Company’s suppliers. Certain suppliers provide upfront allowances to the Company in lieu of accepting the obligation for warranty claims.  For this merchandise, when sold, the Company bears the risk of loss associated with the cost of warranty claims.  Differences between supplier allowances received by the Company, in lieu of warranty obligations and estimated warranty expense, are recorded as an adjustment to cost of sales.  Estimated warranty costs, which are recorded as obligations at the time of sale, are based on the historical failure rate of each individual product line.  The Company’s historical experience has been that failure rates are relatively consistent over time and that the ultimate cost of warranty claims to the Company has been driven by volume of units sold as opposed to fluctuations in failure rates or the variation of the cost of individual claims.

​

The Company’s product warranty liabilities are included in “Other current liabilities” on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024, and December 31, 2023; the following table identifies the changes in the Company’s aggregate product warranty liabilities for the nine months ended September 30, 2024 (in thousands):

​

​

​

​

​

Warranty liabilities, balance at December 31, 2023

​

$

117,895

Warranty claims

​

 

(151,873)

Warranty accruals

​

 

166,195

Foreign currency translation

​

​

(79)

Warranty liabilities, balance at September 30, 2024

​

$

132,138

​

​

NOTE 9 – SHARE REPURCHASE PROGRAM

​

In January of 2011, the Company’s Board of Directors approved a share repurchase program. Under the program, the Company may, from time to time, repurchase shares of its common stock, solely through open market purchases effected through a broker dealer at prevailing market prices, based on a variety of factors such as price, corporate trading policy requirements, and overall market conditions.  The Company’s Board of Directors may increase or otherwise modify, renew, suspend, or terminate the share repurchase program at any time, without prior notice.  As announced on May 23, 2023, and November 16, 2023, the Company’s Board of Directors each time approved a resolution to increase the authorization amount under the share repurchase program by an additional $2.0 billion, resulting in a cumulative authorization amount of $25.8 billion.  The additional authorizations are effective for three years, beginning on their respective announcement date.

11

​

The following table identifies shares of the Company’s common stock that have been repurchased as part of the Company’s publicly announced share repurchase program for the three and nine months ended September 30, 2024 and 2023 (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Shares repurchased

 

​

498

​

​

852

 

​

1,545

​

​

2,961

Average price per share

​

$

1,084.28

​

$

938.11

​

$

1,038.32

​

$

874.99

Total investment

​

$

540,713

​

$

799,520

​

$

1,604,494

​

$

2,590,950

​

As of September 30, 2024, the Company had $967.7 million remaining under its share repurchase authorization.  Excise tax on shares repurchased, assessed at one percent of the fair market value of shares repurchased, was $16.0 million for the nine months ended September 30, 2024.

​

Subsequent to the end of the third quarter and through November 8, 2024, the Company repurchased 0.2 million additional shares of its common stock under its share repurchase program, at an average price of $1,174.84, for a total investment of $192.4 million.  The Company has repurchased a total of 95.8 million shares of its common stock under its share repurchase program since the inception of the program in January of 2011 and through November 8, 2024, at an average price of $260.71, for a total aggregate investment of $25.0 billion.

​

NOTE 10 – ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

​

Accumulated other comprehensive income (loss) includes adjustments for foreign currency translations. The tables below summarize activity for changes in accumulated other comprehensive income (loss) for the three and nine months ended September 30, 2024 and 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Loss

Accumulated other comprehensive income, balance at June 30, 2024

​

$

8,892

​

$

8,892

Change in accumulated other comprehensive loss

​

​

(22,026)

​

​

(22,026)

Accumulated other comprehensive loss, balance at September 30, 2024

​

$

(13,134)

​

$

(13,134)

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Loss

Accumulated other comprehensive income, balance at December 31, 2023

​

$

39,388

​

$

39,388

Change in accumulated other comprehensive loss

​

​

(52,522)

​

​

(52,522)

Accumulated other comprehensive loss, balance at September 30, 2024

​

$

(13,134)

​

$

(13,134)

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Income

Accumulated other comprehensive income, balance at June 30, 2023

​

$

36,071

​

$

36,071

Change in accumulated other comprehensive loss

​

​

(5,782)

​

​

(5,782)

Accumulated other comprehensive income, balance at September 30, 2023

​

$

30,289

​

$

30,289

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Income

Accumulated other comprehensive income, balance at December 31, 2022

​

$

2,996

​

$

2,996

Change in accumulated other comprehensive income

​

​

27,293

​

​

27,293

Accumulated other comprehensive income, balance at September 30, 2023

​

$

30,289

​

$

30,289

(1)Foreign currency translation is not shown net of additional U.S. tax, as other basis differences of non-U.S. subsidiaries are intended to be permanently reinvested.

​

12

NOTE 11 – REVENUE

​

The table below identifies the Company’s revenues disaggregated by major customer type for the three and nine months ended September 30, 2024 and 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Sales to do-it-yourself customers

​

$

2,215,640

​

$

2,206,511

​

$

6,366,670

​

$

6,254,980

Sales to professional service provider customers

 

​

2,032,376

 

​

1,914,884

 

​

5,901,820

 

​

5,480,212

Other sales, sales adjustments, and sales from the acquired Vast Auto stores

 

​

116,421

 

​

81,985

 

​

344,388

 

​

245,043

Total sales

​

$

4,364,437

​

$

4,203,380

​

$

12,612,878

​

$

11,980,235

​

See Note 8 for information concerning the expected costs associated with the Company’s assurance warranty obligations.  See Note 2 for information concerning the recent acquisition of Vast Auto.

​

NOTE 12 – SHARE-BASED COMPENSATION AND BENEFIT PLANS

​

The Company recognizes share-based compensation expense based on the fair value of the grants, awards, or shares at the time of the grant, award, or issuance.  Share-based compensation includes stock option awards, restricted stock awards, and stock appreciation rights issued under the Company’s incentive plans and stock issued through the Company’s employee stock purchase plan.

​

Stock options:

The Company’s incentive plans provide for the granting of stock options for the purchase of common stock of the Company to certain key employees of the Company.  Employee stock options are granted at an exercise price that is equal to the closing market price of the Company’s common stock on the date of the grant.  Employee stock options granted under the plans expire after 10 years and typically vest 25% per year, over four years.  The Company records compensation expense for the grant date fair value of the option awards evenly over the vesting period or minimum required service period.

​

The table below identifies stock option activity under these plans during the nine months ended September 30, 2024 (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

Shares

​

Weighted- Average

​

​

(in thousands)

​

Exercise Price

Outstanding at December 31, 2023

 

884

​

$

428.50

Granted

 

70

​

 

1,061.73

Exercised

 

(291)

​

 

329.59

Forfeited or expired

 

(9)

​

 

676.68

Outstanding at September 30, 2024

 

654

​

$

537.18

Exercisable at September 30, 2024

 

443

​

$

393.93

​

The fair value of each stock option award is estimated on the date of the grant using the Black-Scholes option pricing model. The Black-Scholes model requires the use of assumptions, including the risk-free rate, expected life, expected volatility, and expected dividend yield.

●Risk-free interest rate – The United States Treasury rates in effect at the time the options are granted for the options’ expected life.
●Expected life – Represents the period of time that options granted are expected to be outstanding. The Company uses historical experience to estimate the expected life of options granted.
●Expected volatility – Measure of the amount, by which the Company’s stock price is expected to fluctuate, based on a historical trend.
●Expected dividend yield – The Company has not paid, nor does it have plans in the foreseeable future to pay, any dividends.

​

13

The table below identifies the weighted-average assumptions used for grants awarded during the nine months ended September 30, 2024 and 2023:

​

​

​

​

​

​

​

​

​

​

September 30, 

​

    

2024

​

2023

Risk free interest rate

 

4.18

%  

​

3.92

%  

Expected life

 

6.4

Years

​

6.3

Years

Expected volatility

 

28.2

%  

​

29.0

%  

Expected dividend yield

 

—

%  

​

—

%  

​

The following table summarizes activity related to stock options awarded by the Company for the three and nine months ended September 30, 2024 and 2023 (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

​

2023

Compensation expense for stock options awarded

​

$

5,838

​

$

5,977

​

$

17,175

​

$

17,892

Income tax benefit from compensation expense related to stock options

​

 

1,480

​

 

1,476

​

 

4,355

​

 

4,417

​

The weighted-average grant-date fair value of options granted during the nine months ended September 30, 2024, was $403.77, compared to $321.36 for the nine months ended September 30, 2023.  The remaining unrecognized compensation expense related to unvested stock option awards at September 30, 2024, was $48.7 million, and the weighted-average period of time over which this cost will be recognized is 2.8 years.

​

Other share-based compensation plans:

The Company sponsors other share-based compensation plans:  an employee stock purchase plan and incentive plans that provide for the awarding of shares of restricted stock to certain key employees and directors.  The Company’s employee stock purchase plan (the “ESPP”) permits eligible employees to purchase shares of the Company’s common stock at 85% of the fair market value.  The fair value of shares issued under the ESPP is based on the average of the high and low market prices of the Company’s common stock during the offering periods, and compensation expense is recognized based on the discount between the fair value and the employee purchase price for the shares sold to employees.  Restricted stock awarded under the incentive plans to certain key employees and directors vests after one-year or evenly over a three-year period and is held in escrow until such vesting has occurred.  The fair value of shares awarded under the incentive plans is based on the closing market price of the Company’s common stock on the date of the award, and compensation expense is recorded evenly over the vesting period or the minimum required service period.

​

The table below summarizes activity related to the Company’s other share-based compensation plans for the three and nine months ended September 30, 2024 and 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Compensation expense for shares issued under the ESPP

​

$

1,027

​

$

923

​

$

2,963

​

$

2,663

Income tax benefit from compensation expense related to shares issued under the ESPP

​

​

260

​

​

228

​

​

751

​

​

657

Compensation expense for restricted shares awarded

​

​

506

​

​

477

​

​

1,462

​

​

1,393

Income tax benefit from compensation expense related to restricted awards

​

$

128

​

$

118

​

$

371

​

$

344

​

Profit sharing and savings plan:

The Company sponsors a contributory profit sharing and savings plan (the “401(k) Plan”) that covers substantially all employees who are at least 21 years of age.  The Company makes matching contributions equal to 100% of the first 2% of each employee’s wages that are contributed and 25% of the next 4% of each employee’s wages that are contributed.  The Company may also make additional discretionary profit sharing contributions to the 401(k) Plan on an annual basis as determined by the Board of Directors.  The Company did not make any discretionary contributions to the 401(k) Plan during the nine months ended September 30, 2024 or 2023.  The Company expensed matching contributions under the 401(k) Plan in the amount of $14.0 million and $13.4 million for the three months ended September 30, 2024 and 2023, respectively, which were primarily included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.  The Company expensed matching contributions under the 401(k) Plan in the amount of $40.6 million and $35.9 million for the nine months ended September 30, 2024 and 2023, respectively, which

14

were primarily included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.  

​

Nonqualified deferred compensation plan:

The Company sponsors a nonqualified deferred compensation plan (the “Deferred Compensation Plan”) for highly compensated employees whose contributions to the 401(k) Plan are limited due to the application of the annual limitations under the Internal Revenue Code, which could then be matched by the Company using the same formula as the 401(k) plan.  In the event of bankruptcy, the assets of this plan are available to satisfy the claims of general creditors.  The Company has an unsecured obligation to pay, in the future, the value of the deferred compensation and Company match, if applicable, adjusted to reflect the performance, whether positive or negative, of selected investment measurement options chosen by each participant during the deferral period.  See Note 4 for further information concerning the Company’s marketable securities held to fulfill our future unsecured obligations under this plan.

​

The liability for compensation deferred under the Deferred Compensation Plan was $65.7 million and $59.5 million as of September 30, 2024, and December 31, 2023, respectively, which was included in “Other liabilities” on the accompanying Condensed Consolidated Balance Sheets.  The Company expensed contributions under the Deferred Compensation Plan in the amount of less than $0.1 million for each of the three months ended September 30, 2024 and 2023, which were included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.  The Company expensed matching contributions under the Deferred Compensation Plan in the amount of $0.1 million and less than $0.1 million for the nine months ended September 30, 2024 and 2023, respectively, which were included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.      

​

Stock appreciation rights:

The Company’s incentive plans provide for the granting of stock appreciation rights, which expire after 10 years and vest 25% per year, over four years, and are settled in cash.  As of September 30, 2024, and December 31, 2023, there were 15,044 and 13,079 stock appreciation rights outstanding, respectively.  During the nine months ended September 30, 2024, there were 2,491 stock appreciation rights granted, 350 stock appreciation rights exercised, and 176 stock appreciation rights forfeited.  The liability for compensation to be paid for redeemed stock appreciation rights was $6.7 million and $4.5 million as of September 30, 2024, and December 31, 2023, respectively, which were included in “Other liabilities” on the Condensed Consolidated Balance Sheets.  The Company recorded compensation expense for stock appreciation rights in the amount of $1.4 million and compensation benefit for stock appreciation rights in the amount of $0.1 million for the three months ended September 30, 2024 and 2023, respectively, which were included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.  The Company recorded compensation expense for stock appreciation rights in the amount of $3.1 million and $0.6 million for the nine months ended September 30, 2024 and 2023, respectively, which were included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.

​

NOTE 13 – COMMITMENTS

​

The Company has a conditional agreement to purchase federal renewable energy tax credits (“RETC”).  As of September 30, 2024, the Company had a remaining commitment to purchase approximately $200 million RETCs, with the final closing payment anticipated to occur by June of 2025.

​

15

NOTE 14 – EARNINGS PER SHARE

​

The following table illustrates the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2024 and 2023 (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Numerator (basic and diluted):

 

​

  

 

​

  

 

​

  

 

​

  

Net income

​

$

665,464

​

$

649,827

​

$

1,835,550

​

$

1,794,077

​

​

​

​

​

​

​

​

​

​

​

​

​

Denominator:

​

 

  

​

 

  

​

 

  

​

 

  

Weighted-average common shares outstanding – basic

​

 

57,998

​

 

60,082

​

 

58,563

​

 

60,905

Effect of stock options (1)

​

 

337

​

 

508

​

 

379

​

 

540

Weighted-average common shares outstanding – assuming dilution

​

 

58,335

​

 

60,590

​

 

58,942

​

 

61,445

​

​

​

​

​

​

​

​

​

​

​

​

​

Earnings per share:

​

 

  

​

 

  

​

 

  

​

 

  

Earnings per share-basic

​

$

11.47

​

$

10.82

​

$

31.34

​

$

29.46

Earnings per share-assuming dilution

​

$

11.41

​

$

10.72

​

$

31.14

​

$

29.20

​

​

​

​

​

​

​

​

​

​

​

​

​

Antidilutive potential common shares not included in the calculation of diluted earnings per share:

​

 

  

​

 

  

​

 

  

​

 

  

Stock options (1)

​

 

92

​

 

83

​

 

115

​

 

98

Weighted-average exercise price per share of antidilutive stock options (1)

​

$

1,026.97

​

$

853.21

​

$

977.48

​

$

824.23

(1)See Note 12 for further information concerning the terms of the Company’s share-based compensation plans.

​

For the three and nine months ended September 30, 2024 and 2023, the computation of diluted earnings per share did not include certain securities. These securities represent underlying stock options not included in the computation of diluted earnings per share, because the inclusion of such equity awards would have been antidilutive.

​

See Note 9 for information concerning the Company’s subsequent share repurchases.  

​

NOTE 15 – LEGAL MATTERS

​

The Company is currently involved in litigation incidental to the ordinary conduct of the Company’s business.  Based on existing facts and historical patterns, the Company accrues for litigation losses in instances where an adverse outcome is probable and the Company is able to reasonably estimate the probable loss in accordance with Accounting Standard Codification 450-20.  The Company also accrues for an estimate of legal costs to be incurred for litigation matters.  Although the Company cannot ascertain the amount of liability that it may incur from legal matters, it does not currently believe that, in the aggregate, these matters, taking into account applicable insurance and accruals, will have a material adverse effect on its consolidated financial position, results of operations or cash flows in a particular quarter or annual period.  

​

NOTE 16 – RECENT ACCOUNTING PRONOUNCEMENTS

​

In November of 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standard Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”).  ASU 2023-07 increases the disclosures about a public entity’s reportable segments.  Under ASU 2023-07, a public entity would be required to disclose significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), a description of other segment items by reportable segment, annual disclosures about a reportable segment’s profit or loss and assets required by Topic 280 in interim periods, any additional measures of a segment’s profit or loss used by the CODM to allocate resources, and the title and position of the CODM.  ASU 2023-07 is effective for annual reporting periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024.  ASU 2023-07 allows for early adoption and requires retrospective adoption.  The Company will adopt this guidance beginning with its fourth quarter ending December 31, 2024.  The application of this new guidance is not expected to have a material impact on the Company’s consolidated financial condition, results of operations, or cash flows, as the guidance pertains to disclosure only.

​

16

In December of 2023, FASB issued Accounting Standard Update ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”).  Under ASU 2023-09, a public entity will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold, such as if the effect of the reconciling item is equal to or greater than five percent of the amount computed by multiplying pretax income/loss by the applicable statutory income tax rate.  Entities would also have to disclose the amount of income taxes paid disaggregated by federal, state, and foreign taxes and the amount of income taxes paid disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than five percent of total income taxes paid, along with income/loss from continuing operations before income tax expense disaggregated between domestic and foreign and income tax expense from continuing operations disaggregated by federal, state, and foreign.  ASU 2023-09 is effective for annual reporting periods beginning after December 15, 2024.  ASU 2023-09 allows for early adoption for annual financial statements that have not yet been issued and allows retrospective and prospective adoption.  The Company will adopt this guidance beginning with its fourth quarter ending December 31, 2025.  The application of this new guidance is not expected to have a material impact on the Company’s consolidated financial condition, results of operations, or cash flows, as the guidance pertains to disclosure only.

​

In November of 2024, FASB issued Accounting Standard Update ASU No. 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”).  Under 2024-03, a public entity would be required to disclose information about purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depletion for each income statement line item that contains those expenses.  Entities would also have to disclose other specific expenses, gains, or losses that are already required to be disclosed under GAAP in this same disclosure, a qualitative description of the amounts remaining that are not separately disaggregated quantitatively, and the total amount of selling expenses, as well as an entity’s definition of selling expenses.  ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027.  ASU 2024-03 allows for early adoption and requires either prospective adoption to financial statements issued for reporting periods after the effective date of ASU 2024-03 or retrospectively to any or all prior periods presented in the financial statements.  The Company will adopt this guidance beginning with its fourth quarter ending December 31, 2027.  The application of this new guidance is not expected to have a material impact on the Company’s consolidated financial condition, results of operations, or cash flows, as the guidance pertains to disclosure only.  

​

17

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

​

Unless otherwise indicated, “we,” “us,” “our,” and similar terms, as well as references to the “Company” or “O’Reilly,” refer to O’Reilly Automotive, Inc. and its subsidiaries.

​

In Management’s Discussion and Analysis, we provide a historical and prospective narrative of our general financial condition, results of operations, liquidity, and certain other factors that may affect our future results, including

●an overview of the key drivers and other influences on the automotive aftermarket industry;
●our results of operations for the three and nine months ended September 30, 2024 and 2023;
●our liquidity and capital resources;
●our critical accounting estimates; and
●recent accounting pronouncements that may affect our Company.

​

The review of Management’s Discussion and Analysis should be made in conjunction with our condensed consolidated financial statements, related notes and other financial information, forward-looking statements, and other risk factors included elsewhere in this quarterly report.

​

FORWARD-LOOKING STATEMENTS

​

We claim the protection of the safe-harbor for forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  You can identify these statements by forward-looking words such as “estimate,” “may,” “could,” “will,” “believe,” “expect,” “would,” “consider,” “should,” “anticipate,” “project,” “plan,” “intend,” or similar words.  In addition, statements contained within this quarterly report that are not historical facts are forward-looking statements, such as statements discussing, among other things, expected growth, store development, integration and expansion strategy, business strategies, future revenues, and future performance.  These forward-looking statements are based on estimates, projections, beliefs, and assumptions and are not guarantees of future events and results.  Such statements are subject to risks, uncertainties, and assumptions, including, but not limited to, the economy in general; inflation; consumer debt levels; product demand; a public health crisis; the market for auto parts; competition; weather; tariffs; availability of key products and supply chain disruptions; business interruptions, including terrorist activities, war and the threat of war; failure to protect our brand and reputation; challenges in international markets; volatility of the market price of our common stock; our increased debt levels; credit ratings on public debt; damage, failure, or interruption of information technology systems, including information security and cyber-attacks; historical growth rate sustainability; our ability to hire and retain qualified employees; risks associated with the performance of acquired businesses; and governmental regulations.  Actual results may materially differ from anticipated results described or implied in these forward-looking statements.  Please refer to the “Risk Factors” section of our annual report on Form 10-K for the year ended December 31, 2023, and subsequent Securities and Exchange Commission filings, for additional factors that could materially affect our financial performance.  Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

​

OVERVIEW

​

We are a specialty retailer of automotive aftermarket parts, tools, supplies, equipment, and accessories in the United States, Puerto Rico, Mexico, and Canada.  We are one of the largest U.S. automotive aftermarket specialty retailers, selling our products to both DIY customers and professional service providers – our “dual market strategy.”  Our goal is to achieve growth in sales and profitability by capitalizing on our competitive advantages, such as our dual market strategy, superior customer service provided by well-trained and technically proficient Team Members, and strategic distribution and hub store network that provides same day and over-night inventory access for our stores to offer a broad selection of product offerings.  The successful execution of our growth strategy includes aggressively opening new stores, growing sales in existing stores, continually enhancing merchandising and store layouts, and implementing our Omnichannel initiatives.  As of September 30, 2024, we operated 6,187 stores in 48 U.S. states and Puerto Rico, 78 stores in Mexico, and 26 stores in Canada.

​

See Note 2 “Business Combination” to the Condensed Consolidated Financial Statements for further information concerning the recent acquisition of Vast Auto.  

​

The extensive product line offered in our stores consists of new and remanufactured automotive hard parts, maintenance items, accessories, a complete line of auto body paint and related materials, automotive tools, and professional service provider service equipment.  Our extensive product line includes an assortment of products that are differentiated by quality and price for most of the product lines we offer.  For many of our product offerings, this quality differentiation reflects “good,” “better,” and “best” alternatives.  

18

Our sales and total gross profit dollars are, generally, highest for the “best” quality category of products.  Consumers’ willingness to select products at a higher point on the value spectrum is a driver of enhanced sales and profitability in our industry.  We have ongoing initiatives focused on marketing and training to educate customers on the advantages of ongoing vehicle maintenance, as well as “purchasing up” on the value spectrum.

​

Our stores also offer enhanced services and programs to our customers, including used oil, oil filter, and battery recycling; battery, wiper, and bulb replacement; battery diagnostic testing; electrical and module testing; check engine light code extraction; loaner tool program; drum and rotor resurfacing; custom hydraulic hoses; professional paint shop mixing and related materials; and machine shops.

​

Our business is influenced by a number of general macroeconomic factors that impact both our industry and consumers, including, but not limited to, inflation, including rising consumer staples; fuel and energy costs; unemployment trends; interest rates; and other economic factors.  Future changes, such as continued broad-based inflation and rapid fuel cost increases that exceed wage growth, may negatively impact our consumers’ level of disposable income, and we cannot predict the degree these changes, or other future changes, may have on our business or industry.

​

We believe the key drivers of demand over the long-term for the products sold within the automotive aftermarket include the number of U.S. miles driven, number of U.S. registered vehicles, annual rate of light vehicle sales, and average vehicle age.

​

Number of Miles Driven 

The number of total miles driven in the U.S. influences the demand for repair and maintenance products sold within the automotive aftermarket.  In total, vehicles in the U.S. are driven approximately three trillion miles per year, resulting in ongoing wear and tear and a corresponding continued demand for the repair and maintenance products necessary to keep these vehicles in operation.  According to the U.S. Department of Transportation, the number of total miles driven in the U.S. increased 0.9% and 2.1% in 2022 and 2023, respectively, and year-to-date through August of 2024, miles driven have increased 0.9%.  Total miles driven can be impacted by macroeconomic factors, including rapid increases in fuel cost, but we are unable to predict the degree of impact these factors may have on miles driven in the future.  

​

Size and Age of the Vehicle Fleet

The total number of vehicles on the road and the average age of the vehicle population heavily influence the demand for products sold within the automotive aftermarket industry.  As reported by the Auto Care Association, the total number of registered vehicles increased 14.2% from 2013 to 2023, bringing the number of light vehicles on the road to 284 million by the end of 2023.  For the year ended December 31, 2023, the seasonally adjusted annual rate of light vehicle sales in the U.S. (“SAAR”) was approximately 15.8 million vehicles, and for 2024, the SAAR is estimated to be approximately 15.8 million vehicles, contributing to the continued growth in the total number of registered vehicles on the road.  From 2013 to 2023, vehicle scrappage rates have remained relatively stable, ranging from 4.1% to 5.7% annually.  As a result, over the past decade, the average age of the U.S. vehicle population has increased, growing 10.6%, from 11.3 years in 2013 to 12.5 years in 2023.  While the annual changes to the vehicle population resulting from new vehicle sales and the fluctuation in vehicle scrappage rates in any given year represent a small percentage of the total light vehicle population and have a muted impact on the total number and average age of vehicles on the road over the short term, we believe our business benefits from the current environment of elevated new and used vehicle prices, as consumers are more willing to continue to invest in their current vehicle.  

​

We believe the increase in average vehicle age over the long term can be attributed to better engineered and manufactured vehicles, which can be reliably driven at higher mileages due to better quality power trains, interiors and exteriors, coupled with consumers’ willingness to invest in maintaining these higher-mileage, better built vehicles.  As the average age of vehicles on the road increases, a larger percentage of miles are being driven by vehicles that are outside of a manufacturer warranty.  These out-of-warranty, older vehicles generate strong demand for automotive aftermarket products as they go through more routine maintenance cycles, have more frequent mechanical failures, and generally require more maintenance than newer vehicles.  We believe consumers will continue to invest in these reliable, higher-quality, higher-mileage vehicles, and these investments, along with an increasing total light vehicle fleet, will support continued demand for automotive aftermarket products.

​

Inflationary cost pressures impact our business; however, historically we have been successful, in many cases, in reducing the effects of merchandise cost increases, principally by taking advantage of supplier incentive programs, economies of scale resulting from increased volume of purchases and selective forward buying.  To the extent our acquisition costs increase due to base commodity price increases or other input cost increases affecting the entire industry, we have typically been able to pass along these cost increases through higher selling prices for the affected products.  As a result, we do not believe inflation has had a material adverse effect on our operations.

​

To some extent, our business is seasonal, primarily as a result of the impact of weather conditions on customer buying patterns.  While we have historically realized operating profits in each quarter of the year, our store sales and profits have historically been higher in the second and third quarters (April through September) than in the first and fourth quarters (October through March) of the year.

19

​

We remain confident in our ability to gain market share in our existing markets and grow our business in new markets by focusing on our dual market strategy and the core O’Reilly values of hard work and excellent customer service.    

​

RESULTS OF OPERATIONS

​

Sales:

Sales for the three months ended September 30, 2024, increased $161 million, or 4%, to $4.36 billion from $4.20 billion for the same period one year ago.  Sales for the nine months ended September 30, 2024, increased $633 million or 5% to $12.61 billion from $11.98 billion for the same period one year ago.  Comparable store sales for stores open at least one year increased 1.5% and 8.7% for the three months ended September 30, 2024 and 2023, respectively.  Comparable store sales for stores open at least one year increased 2.4% and 9.4% for the nine months ended September 30, 2024 and 2023, respectively.  Comparable store sales are calculated based on the change in sales for U.S. stores open at least one year and exclude sales of specialty machinery, sales to independent parts stores, and sales to Team Members, as well as sales from Leap Day in the nine months ended September 30, 2024.  Online sales for ship-to-home orders and pickup in-store orders for U.S. stores open at least one year are included in the comparable store sales calculation. We opened 47 and 111 net, new stores during the three and nine months ended September 30, 2024, respectively, compared to opening 40 and 140 net, new stores during the three and nine months ended September 30, 2023, respectively.  Additionally, we began operating 23 stores in Canada from the Vast Auto acquisition during the nine months ended September 30, 2024.  We anticipate total new store growth to be 190 to 200 net, new store openings in 2024.  We anticipate total new store growth to be 200 to 210 net, new store openings in 2025.

​

The increase in sales for the three months ended September 30, 2024, was primarily the result of the 1.5% increase in domestic comparable store sales, a $66 million increase in sales from new stores opened in 2023 and 2024 that are not considered comparable stores, and sales from the acquired Vast Auto stores.  The increase in sales for the nine months ended September 30, 2024, was primarily the result of 2.4% increase in domestic comparable store sales, a $210 million increase in sales from new stores opened in 2023 and 2024 that are not considered comparable stores, sales from the acquired Vast Auto stores, and sales from one additional day due to Leap Day.  Our comparable store sales increases for the three and nine months ended September 30, 2024, were driven by increases in average ticket values for both professional service provider and DIY customers and positive transaction counts from professional service provider customers, partially offset by negative transaction counts from DIY customers.  Average ticket values benefited from inflationary increases in average selling prices, as compared to the same periods in 2023.  Average ticket values also continue to be positively impacted by the increasing complexity and cost of replacement parts necessary to maintain the current population of better-engineered and more technically advanced vehicles.  These better-engineered, more technically advanced vehicles require less frequent repairs, as the component parts are more durable and last for longer periods of time.  The resulting decrease in repair frequency creates pressure on customer transaction counts; however, when repairs are needed, the cost of replacement parts is, on average, greater, which is a benefit to average ticket values.  The decreases in DIY customer transaction counts were driven by pressured consumer spending on discretionary categories and broader industry pressure in certain repair related hard part categories.  

​

See Note 2 “Business Combination” to the Condensed Consolidated Financial Statements for further information concerning the recent acquisition of Vast Auto.  See Note 11 “Revenue” to the Condensed Consolidated Financial Statements for further information concerning the Company’s sales.  

​

Gross profit:

Gross profit for the three months ended September 30, 2024, increased 4% to $2.25 billion (or 51.6% of sales) from $2.16 billion (or 51.4% of sales) for the same period one year ago.  Gross profit for the nine months ended September 30, 2024, increased 5% to $6.45 billion (or 51.2% of sales) from $6.14 billion (or 51.2% of sales) for the same period one year ago.  The increase in gross profit dollars for the three months ended September 30, 2024, was primarily the result of the increase in comparable store sales at existing stores and sales from new and acquired stores.  The increase in gross profit dollars for the nine months ended September 30, 2024, was primarily the result of the increase in comparable store sales at existing stores, sales from new and acquired stores, and one additional day due to Leap Day.  The increase in gross profit as a percentage of sales for the three months ended September 30, 2024, was primarily due to improved acquisition costs, partially offset by a greater percentage of our total sales mix being generated from professional service provider customers, which carry a lower gross margin than DIY sales, and the inclusion of the lower gross margin sales from the acquired Vast Auto business.  Gross profit as a percentage of sales for the nine months ended September 30, 2024, was flat.  

​

Selling, general and administrative expenses:

Selling, general and administrative expenses (“SG&A”) for the three months ended September 30, 2024, increased 7% to $1.35 billion (or 31.0% of sales) from $1.26 billion (or 30.1% of sales) for the same period one year ago.  SG&A for the nine months ended September 30, 2024, increased 7% to $3.94 billion (or 31.2% of sales) from $3.67 billion (or 30.6% of sales) for the same period one year ago.  The increase in total SG&A dollars for the three months ended September 30, 2024, was primarily the result of additional Team Members and vehicles to support our increased sales and store count and SG&A associated with the Vast Auto operations.  The

20

increase in total SG&A dollars for the nine months ended September 30, 2024, was primarily the result of additional Team Members and vehicles to support our increased sales and store count, SG&A associated with the Vast Auto acquisition and operations, and one additional day due to Leap Day.  The increases in SG&A as a percentage of sales for the three and nine months ended September 30, 2024, were principally due to depreciation costs for the accelerated refreshment of store related capital expenditures and information technology investments.  

​

Operating income:

As a result of the impacts discussed above, operating income for the three months ended September 30, 2024, was $897 million (or 20.5% of sales), which was flat compared to $897 million (or 21.3% of sales) for the same period one year ago.  As a result of the impacts discussed above, operating income for the nine months ended September 30, 2024, increased 2% to $2.51 billion (or 19.9% of sales) from $2.47 billion (or 20.6% of sales) for the same period one year ago.    

​

Other income and expense:

Total other expense for the three months ended September 30, 2024, decreased 3% to $49 million (or 1.1% of sales) from $51 million (or 1.2% of sales) for the same period one year ago.  Total other expense for the nine months ended September 30, 2024, increased 14% to $153 million (or 1.2% of sales) from $134 million (or 1.1% of sales) for the same period one year ago.  The decrease in total other expense for the three months ended September 30, 2024, was the result of an increase in the value of our trading securities, as compared to a decrease in the same period in 2023, partially offset by increased interest expense on higher average outstanding borrowings.  The increase in total other expense for the nine months ended September 30, 2024, was the result of increased interest expense on higher average outstanding borrowings.  See Note 4 “Fair Value Measurements” to the Condensed Consolidated Financial Statements for further information concerning the Company’s trading securities.  See Note 7 “Financing” to the Condensed Consolidated Financial Statements for further information concerning the Company’s borrowings.    

​

Income taxes:

Our provision for income taxes for the three months ended September 30, 2024, decreased 7% to $182 million (21.5% effective tax rate) from $197 million (23.2% effective tax rate) for the same period one year ago.  Our provision for income taxes for the nine months ended September 30, 2024, decreased 3% to $524 million (22.2% effective tax rate) from $539 million (23.1% effective tax rate) for the same period one year ago.  The decreases in our provision for income taxes and our effective tax rate for the three and nine months ended September 30, 2024, were the result of higher excess tax benefits from share-based compensation in the current period, as compared to the same period one year ago.    

​

Net income:

As a result of the impacts discussed above, net income for the three months ended September 30, 2024, increased 2% to $665 million (or 15.2% of sales) from $650 million (or 15.5% of sales) for the same period one year ago.  As results of the impacts discussed above, net income for the nine months ended September 30, 2024, increased 2% to $1.84 billion (or 14.6% of sales) from $1.79 billion (or 15.0% of sales) for the same period one year ago.    

​

Earnings per share:

Our diluted earnings per common share for the three months ended September 30, 2024, increased 6% to $11.41 on 58 million shares from $10.72 on 61 million shares for the same period one year ago.  Our diluted earnings per common share for the nine months ended September 30, 2024, increased 7% to $31.14 on 59 million shares from $29.20 on 61 million shares for the same period one year ago.

​

LIQUIDITY AND CAPITAL RESOURCES

​

Our long-term business strategy requires capital to maintain and enhance our existing stores, invest to open new stores, fund strategic acquisitions, expand distribution infrastructure, and develop enhanced information technology systems and tools and may include the opportunistic repurchase of shares of our common stock through our Board-approved share repurchase program.  Our material cash requirements necessary to maintain the current operations of our long-term business strategy include, but are not limited to, inventory purchases; human capital obligations, including payroll and benefits; contractual obligations, including debt and interest obligations; capital expenditures; payment of income taxes; and other operational priorities.  We expect to fund our short- and long-term cash and capital requirements with our primary sources of liquidity, which include funds generated from the normal course of our business operations, borrowings under our unsecured revolving credit facility and our commercial paper program, and senior note offerings.  However, there can be no assurance that we will continue to generate cash flows or maintain liquidity at or above recent levels, as we are unable to predict decreased demand for our products or changes in customer buying patterns.  Additionally, these factors could also impact our ability to meet the debt covenants of our credit agreement and, therefore, negatively impact the funds available under our unsecured revolving credit facility.

​

21

Other than the commitment discussed in Note 13 “Commitments” to the Condensed Consolidated Financial Statements, there have been no material changes to the contractual obligations, to which we are committed, since those discussed in our annual report on Form 10-K for the year ended December 31, 2023.

​

The following table identifies cash provided by/(used in) our operating, investing and financing activities for the nine months ended September 30, 2024 and 2023 (in thousands):

​

​

​

​

​

​

​

​

​

For the Nine Months Ended

​

​

September 30, 

Liquidity:

    

2024

    

2023

Total cash provided by/(used in):

 

​

  

 

​

  

Operating activities

​

$

2,425,089

​

$

2,517,655

Investing activities

​

 

(883,608)

​

 

(749,773)

Financing activities

​

 

(1,704,093)

​

 

(1,794,694)

Effect of exchange rate changes on cash

​

​

(907)

​

​

893

Net decrease in cash and cash equivalents

​

$

(163,519)

​

$

(25,919)

​

​

​

​

​

​

​

Capital expenditures

​

$

732,916

​

$

753,958

Free cash flow (1)

​

​

1,657,129

​

​

1,731,695

(1)Calculated as net cash provided by operating activities, less capital expenditures, excess tax benefit from share-based compensation payments, and investment in tax credit equity investments for the period.  See page 24 for the reconciliation of the calculation of free cash flow.

​

Operating activities:

The decrease in net cash provided by operating activities during the nine months ended September 30, 2024, compared to the same period in 2023, was primarily due to a smaller increase in income taxes payable, due to the timing of tax payments related to benefits from federal renewable energy tax credits, partially offset by an increase in operating income.

​

Investing activities:

The increase in net cash used in investing activities during the nine months ended September 30, 2024, compared to the same period in 2023, was the result of the acquisition of Vast Auto, partially offset by a decrease in capital expenditures.  The decrease in capital expenditures was primarily due to the timing of property acquisitions, closings, construction costs for new stores, partially offset by an increase in the number of owned new store openings in the current period, as compared to the same period in the prior year.

​

Financing activities:

The decrease in net cash used in financing activities during the nine months ended September 30, 2024, compared to the same period in 2023, was attributable to a lower level of repurchases of our common stock in the current period, the issuance of $500 million aggregate principal amount of senior notes in the current period, and the redemption of $300 million aggregate principal amount of senior notes in the same period in 2023, partially offset by a net paydown on the Company’s commercial paper issuances in the current period versus net borrowings on the Company’s commercial paper program during the same period in 2023.

​

Debt instruments:

See Note 7 “Financing” to the Condensed Consolidated Financial Statements for information concerning the Company’s credit agreement, unsecured revolving credit facility, outstanding letters of credit, commercial paper program, and unsecured senior notes.

​

Debt covenants:

The indentures governing our senior notes contain covenants that limit our ability and the ability of certain of our subsidiaries to, among other things, create certain liens on assets to secure certain debt and enter into certain sale and leaseback transactions, and limit our ability to merge or consolidate with another company or transfer all or substantially all of our property, in each case as set forth in the indentures.  These covenants are, however, subject to a number of important limitations and exceptions.  As of September 30, 2024, we were in compliance with the covenants applicable to our senior notes.

​

The Credit Agreement contains certain covenants, including limitations on indebtedness, a minimum consolidated fixed charge coverage ratio of 2.50:1.00 and a maximum consolidated leverage ratio of 3.50:1.00.  The consolidated fixed charge coverage ratio includes a calculation of earnings before interest, taxes, depreciation, amortization, rent, and non-cash share-based compensation expense to fixed charges.  Fixed charges include interest expense, capitalized interest, and rent expense.  The consolidated leverage ratio includes a calculation of adjusted debt to earnings before interest, taxes, depreciation, amortization, rent, and non-cash share-based compensation expense.  Adjusted debt includes outstanding debt, outstanding stand-by letters of credit, and similar instruments, five-times rent expense and excludes any premium or discount recorded in conjunction with the issuance of long-term debt.  In the event that we should default

22

on any covenant contained within the Credit Agreement, certain actions may be taken, including, but not limited to, possible termination of commitments, immediate payment of outstanding principal amounts plus accrued interest and other amounts payable under the Credit Agreement, and litigation from our lenders.

​

We had a consolidated fixed charge coverage ratio of 6.14 times and 6.56 times as of September 30, 2024 and 2023, respectively, and a consolidated leverage ratio of 1.85 times and 1.83 times as of September 30, 2024 and 2023, respectively, remaining in compliance with all covenants related to the borrowing arrangements.

​

The table below outlines the calculations of the consolidated fixed charge coverage ratio and consolidated leverage ratio covenants, as defined in the Credit Agreement governing the Revolving Credit Facility, for the twelve months ended September 30, 2024 and 2023 (dollars in thousands):

​

​

​

​

​

​

​

​

​

​

​

For the Twelve Months Ended

​

​

​

September 30, 

​

​

    

2024

    

2023

GAAP net income

​

$

2,388,054

​

$

2,322,649

Add:

Interest expense

​

 

223,293

​

 

187,851

​

Rent expense (1)

​

 

444,166

​

 

417,988

​

Provision for income taxes

​

 

643,344

​

 

656,817

​

Depreciation expense

​

 

449,207

​

 

392,354

​

Amortization expense

​

 

2,595

​

 

4,114

​

Non-cash share-based compensation

​

 

27,163

​

 

29,493

Non-GAAP EBITDAR

​

$

4,177,822

​

$

4,011,266

​

​

​

​

​

​

​

​

Interest expense

​

$

223,293

​

$

187,851

​

Capitalized interest

​

 

12,975

​

 

6,025

​

Rent expense (1)

​

 

444,166

​

 

417,988

Total fixed charges

​

$

680,434

​

$

611,864

​

​

​

​

​

​

​

​

Consolidated fixed charge coverage ratio

​

 

6.14

​

 

6.56

​

​

​

​

​

​

​

​

GAAP debt

​

$

5,359,810

​

$

5,102,350

Add:

Stand-by letters of credit

​

 

127,234

​

 

111,732

​

Unamortized discount and debt issuance costs

​

 

30,190

​

 

27,650

​

Five-times rent expense

​

 

2,220,830

​

 

2,089,940

Non-GAAP adjusted debt

​

$

7,738,064

​

$

7,331,672

​

​

​

​

​

​

​

​

Consolidated leverage ratio

​

 

1.85

​

 

1.83

(1)The table below outlines the calculation of Rent expense and reconciles Rent expense to Total lease cost, per Accounting Standard Codification 842 (“ASC 842”) the most directly comparable GAAP financial measure, for the twelve months ended September 30, 2024 and 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

For the Twelve Months Ended

​

​

September 30, 

​

​

2024

​

2023

Total lease cost, per ASC 842

    

$

530,689

​

$

495,360

Less:

Variable non-contract operating lease components, related to property taxes and insurance

​

 

86,523

​

 

77,372

Rent expense

​

$

444,166

​

$

417,988

​

23

The table below outlines the calculation of Free cash flow and reconciles Free cash flow to Net cash provided by operating activities, the most directly comparable GAAP financial measure, for the nine months ended September 30, 2024 and 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

For the Nine Months Ended

​

​

​

September 30, 

​

​

    

2024

    

2023

Cash provided by operating activities

​

$

2,425,089

​

$

2,517,655

Less:

Capital expenditures

​

 

732,916

​

 

753,958

​

Excess tax benefit from share-based compensation payments

​

 

35,044

​

 

27,852

​

Investment in tax credit equity investments

​

 

—

​

 

4,150

Free cash flow

​

$

1,657,129

​

$

1,731,695

​

Free cash flow, the consolidated fixed charge coverage ratio, and the consolidated leverage ratio discussed and presented in the tables above are not derived in accordance with United States generally accepted accounting principles (“GAAP”).  We do not, nor do we suggest investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, GAAP financial information.  We believe that the presentation of our free cash flow, consolidated fixed charge coverage ratio, and consolidated leverage ratio provides meaningful supplemental information to both management and investors and reflects the required covenants under the Credit Agreement.  We include these items in judging our performance and believe this non-GAAP information is useful to investors as well.  Material limitations of these non-GAAP measures are that such measures do not reflect actual GAAP amounts.  We compensate for such limitations by presenting, in the tables above, a reconciliation to the most directly comparable GAAP measures.

​

Share repurchase program:

See Note 9 “Share Repurchase Program” to the Consolidated Financial Statements for information on our share repurchase program.  

​

CRITICAL ACCOUNTING ESTIMATES

​

The preparation of our financial statements in accordance with GAAP requires the application of certain estimates and judgments by management.  Management bases its assumptions, estimates, and adjustments on historical experience, current trends and other factors believed to be relevant at the time the condensed consolidated financial statements are prepared. There have been no material changes in the critical accounting estimates since those discussed in our annual report on Form 10-K for the year ended December 31, 2023.

​

RECENT ACCOUNTING PRONOUNCEMENTS

​

See Note 16 “Recent Accounting Pronouncements” to the Condensed Consolidated Financial Statements for information about recent accounting pronouncements.

​

Item 3. Quantitative and Qualitative Disclosures about Market Risk

​

Interest rate risk:

We are subject to interest rate risk to the extent we borrow against our unsecured revolving credit facility (the “Revolving Credit Facility”) with variable interest rates based on either an Alternative Base Rate or Adjusted Term SOFR Rate, as defined in the credit agreement governing the Revolving Credit Facility.  As of September 30, 2024, we had no outstanding borrowings under our Revolving Credit Facility.  

​

We are also subject to interest rate risk to the extent we issue short-term, unsecured commercial paper notes under our commercial paper program (the “Program”) with variable interest rates.  As of September 30, 2024, we had outstanding borrowings under the Program in the amount of $40.0 million, at the weighted-average variable interest rate of 4.980%.  At this borrowing level, a 10% increase in interest rates would have had an unfavorable annual impact on our pre-tax earnings and cash flows in the amount of $0.2 million.

​

Cash equivalents risk:

We invest certain of our excess cash balances in short-term, highly-liquid instruments with maturities of 90 days or less.  We do not expect any material losses from our invested cash balances and we believe that our interest rate exposure is minimal.  As of September 30, 2024, our cash and cash equivalents totaled $115.6 million.

​

Foreign currency risk:

Foreign currency exposures arising from transactions include firm commitments and anticipated transactions denominated in a currency other than our entities’ functional currencies.  To minimize our risk, we generally enter into transactions denominated in the respective

24

functional currencies. Our foreign currency exposure arises from Mexican peso-denominated and Canadian dollar-denominated revenues and profits and their respective translations into U.S. dollars.

​

We view our investments in Mexican subsidiaries as long-term.  The net asset exposure in the Mexican subsidiaries translated into U.S. dollars using the period-end exchange rates was $330.9 million at September 30, 2024.  The period-end exchange rate of the Mexican peso, relative to the U.S. dollar, weakened by approximately 13.8% from December 31, 2023.  The potential loss in value of our net assets in the Mexican subsidiaries resulting from a 10% change in quoted foreign currency exchange rates at September 30, 2024, would be approximately $30.1 million.  Any changes in our net assets in the Mexican subsidiaries relating to foreign currency exchange rates would be reflected in the financial statements through the foreign currency translation component of accumulated other comprehensive income, unless the Mexican subsidiaries are sold or otherwise disposed.  A 10% change in average exchange rates would not have had a material impact on our results of operations.

​

We view our investments in Canadian subsidiaries as long-term.  The net asset exposure in the Canadian subsidiaries translated into U.S. dollars using the period-end exchange rates was $175.6 million at September 30, 2024.  The period-end exchange rate of the Canadian dollar, relative to the U.S. dollar, weakened by approximately 2.1% from December 31, 2023.  The potential loss in value of our net assets in the Canadian subsidiaries resulting from a 10% change in quoted foreign currency exchange rates at September 30, 2024, would be approximately $16.0 million.  Any changes in our net assets in the Canadian subsidiaries relating to foreign currency exchange rates would be reflected in the financial statements through the foreign currency translation component of accumulated other comprehensive income, unless the Canadian subsidiaries are sold or otherwise disposed.  A 10% change in average exchange rates would not have had a material impact on our results of operations.

​

Our market risks have not materially changed since those discussed in our annual report on Form 10-K for the year ended December 31, 2023.

​

Item 4. Controls and Procedures

​

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

​

As of the end of the period covered by this report, the management of the Company, under the supervision and with the participation of its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15(b) and as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (“the Exchange Act”).  Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of the end of the period covered by this report are functioning effectively to provide reasonable assurance that the information required to be disclosed by the Company, including its consolidated subsidiaries, in reports filed under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

​

CHANGES IN INTERNAL CONTROLS

​

There were no changes in the Company’s internal control over financial reporting during the fiscal quarter ended September 30, 2024, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

​

25

PART II. OTHER INFORMATION

​

Item 1. Legal Proceedings

​

The Company is currently involved in litigation incidental to the ordinary conduct of the Company’s business.  Based on existing facts and historical patterns, the Company accrues for litigation losses in instances where an adverse outcome is probable and the Company is able to reasonably estimate the probable loss in accordance with Accounting Standard Codification 450-20.  The Company also accrues for an estimate of legal costs to be incurred for litigation matters.  Although the Company cannot ascertain the amount of liability that it may incur from legal matters, it does not currently believe that, in the aggregate, these matters, taking into account applicable insurance and accruals, will have a material adverse effect on its consolidated financial position, results of operations or cash flows in a particular quarter or annual period.  

​

Item 1A. Risk Factors

​

As of September 30, 2024, there have been no material changes to the risk factors set forth in our annual report on Form 10-K for the year ended December 31, 2023.  

​

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

​

The Company had no sales of unregistered securities during the nine months ended September 30, 2024.  The following table identifies all repurchases during the three months ended September 30, 2024, of any of the Company’s securities registered under Section 12 of the Securities Exchange Act of 1934, as amended, by or on behalf of the Company or any affiliated purchaser (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Total Number of

    

Maximum Dollar Value

​

​

Total

​

Average

​

Shares Purchased as

​

of Shares that May Yet

​

​

Number of

​

Price Paid

​

Part of Publicly

​

Be Purchased Under the

Period

​

Shares Purchased

​

per Share

​

Announced Programs

​

Programs (1)

July 1, 2024, to July 31, 2024

 

247

​

$

1,043.47

 

247

​

$

1,250,892

August 1, 2024, to August 31, 2024

 

130

​

 

1,123.29

 

130

​

 

1,104,360

September 1, 2024, to September 30, 2024

 

121

​

 

1,125.30

 

121

​

$

967,707

Total as of September 30, 2024

 

498

​

$

1,084.28

 

498

​

 

  

(1)The authorization under the share repurchase program that currently has capacity is scheduled to expire on November 16, 2026.  No other share repurchase programs existed during the nine months ended September 30, 2024.  See Note 9 “Share Repurchase Program” to the Condensed Consolidated Financial Statements for further information on our share repurchases.

​

Item 5. Other Information

​

(c) Rule 10b5-1 Trading Plan Elections:

None of the Company’s Directors or Officers adopted, modified, or terminated a Rule 10b5-1 trading agreement or a non-Rule 10b5-1 trading agreement, as defined in Item 408(c) of Regulation S-K, during the Company’s fiscal quarter ended September 30, 2024.

​

​

26

Item 6. Exhibits

​

Exhibit No.

    

Description

​

3.1

​

Second Amended and Restated Articles of Incorporation of the Registrant, filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K dated May 19, 2020, is incorporated herein by this reference.

​

3.2

​

Fourth Amended and Restated Bylaws of the Registrant, filed as Exhibit 3.3 to the Registrant’s Current Report on Form 8-K dated May 19, 2020, is incorporated herein by this reference.

​

4.1

​

Sixth Supplemental Indenture, dated as of August 19, 2024, by and between O’Reilly Automotive, Inc. and U.S. Bank Trust Company, National Association, as Trustee, filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K dated August 19, 2024, is incorporated herein by this reference.

​

4.2

​

Form of Note for 5.000% Senior Notes due 2034, included in Exhibit 4.1 to the Registrant’s Current Report on Form 8-K dated August 19, 2024, is incorporated herein by this reference.

​

31.1

​

Certificate of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.

​

31.2

​

Certificate of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.

​

32.1 *

​

Certificate of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, furnished herewith.

​

32.2 *

​

Certificate of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, furnished herewith.

​

101.INS

​

iXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

​

101.SCH

​

iXBRL Taxonomy Extension Schema.

​

101.CAL

​

iXBRL Taxonomy Extension Calculation Linkbase.

​

101.DEF

​

iXBRL Taxonomy Extension Definition Linkbase.

​

101.LAB

​

iXBRL Taxonomy Extension Label Linkbase.

​

101.PRE

​

iXBRL Taxonomy Extension Presentation Linkbase.

​

104

​

Cover Page Interactive Data File, formatted as Inline XBRL, contained in Exhibit 101 attachments.

​

​

​

​

​

*

​

Furnished (and not filed) herewith pursuant to Item 601(b)(32)(ii) of Regulation S-K.

​

​

​

​

27

SIGNATURES

​

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​

​

​

​

​

​

​

​

O’REILLY AUTOMOTIVE, INC.

​

​

​

​

​

​

November 8, 2024

​

/s/

Brad Beckham

​

Date

​

Brad Beckham

​

​

​

Chief Executive Officer

​

​

​

(Principal Executive Officer)

​

​

​

​

​

​

November 8, 2024

​

/s/

Jeremy A. Fletcher

​

Date

​

Jeremy A. Fletcher

​

​

​

Executive Vice President and Chief Financial Officer

​

​

​

(Principal Financial and Accounting Officer)

​

​

​

​

​

​

28

Exhibit 31.1 - CEO Certification

​

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

​

CERTIFICATIONS

​

I, Brad Beckham, certify that:

​

1.    I have reviewed this report on Form 10-Q of O’Reilly Automotive, Inc.;

​

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

​

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

​

4.    The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

​

(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

​

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

​

(c)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

​

(d)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

​

5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

​

(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

​

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

​

​

​

​

​

​

​

Date:

November 8, 2024

​

/s/

Brad Beckham

​

​

​

​

Brad Beckham

​

​

​

​

Chief Executive Officer

​

​

​

​

(Principal Executive Officer)

​

​

​

​

​

​

​

Exhibit 31.2 - CFO Certification

​

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

​

CERTIFICATIONS

​

I, Jeremy A. Fletcher, certify that:

​

1.    I have reviewed this report on Form 10-Q of O’Reilly Automotive, Inc.;

​

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

​

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

​

4.    The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

​

(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

​

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

​

(c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

​

(d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

​

5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

​

(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

​

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

​

​

​

​

​

​

​

Date:

November 8, 2024

​

/s/

Jeremy A. Fletcher

​

​

​

​

Jeremy A. Fletcher

​

​

​

​

Executive Vice President and

​

​

​

​

Chief Financial Officer

​

​

​

​

(Principal Financial and Accounting Officer)

​

​

Exhibit 32.1 - CEO Certification

​

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

​

O’REILLY AUTOMOTIVE, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

​

In connection with the Report of O’Reilly Automotive, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brad Beckham, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

​

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

​

(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

​

​

​

​

/s/

Brad Beckham

​

Brad Beckham

​

Chief Executive Officer

​

​

November 8, 2024

​

This certification is made solely for purposes of 18 U.S.C. Section 1350, and not for any other purpose.  This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

​

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Exhibit 32.2 - CFO Certification

​

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

​

O’REILLY AUTOMOTIVE, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

​

In connection with the Report of O’Reilly Automotive, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jeremy A. Fletcher, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

​

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

​

(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

​

​

​

​

/s/

Jeremy A. Fletcher

​

Jeremy A. Fletcher

​

Chief Financial Officer

​

​

November 8, 2024

​

This certification is made solely for purposes of 18 U.S.C. Section 1350, and not for any other purpose.  This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

​

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

v3.24.3
Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2024
Nov. 04, 2024
Document and Entity Information    
Document type 10-Q  
Document quarterly report true  
Document transition report false  
Amendment flag false  
Current fiscal year end date --12-31  
Document period end date Sep. 30, 2024  
Document fiscal year focus 2024  
Document fiscal period focus Q3  
Entity registrant name O Reilly Automotive Inc  
Entity central index key 0000898173  
Entity incorporation, state MO  
Entity file number 000-21318  
Entity tax identification number 27-4358837  
Entity address, address 233 South Patterson Avenue  
Entity address, city Springfield  
Entity address, postal zip code 65802  
Entity address, state MO  
City area code 417  
Local phone number 862-6708  
Title of 12(b) security Common Stock,  
Trading symbol ORLY  
Security exchange name NASDAQ  
Entity current reporting status Yes  
Entity filer category Large Accelerated Filer  
Entity small business false  
Entity emerging growth company false  
Entity interactive data current Yes  
Entity shell company false  
Entity common stock, shares outstanding   57,730,693
v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
 [1]
Assets    
Cash and cash equivalents $ 115,613 $ 279,132
Accounts receivable, net 401,950 375,049
Amounts receivable from suppliers 154,300 140,443
Inventory 4,913,237 4,658,367
Other current assets 113,187 105,311
Total current assets 5,698,287 5,558,302
Property and equipment, at cost 8,969,137 8,312,367
Less: accumulated depreciation and amortization 3,532,755 3,275,387
Net property and equipment 5,436,382 5,036,980
Operating lease, right-of-use assets 2,269,929 2,200,554
Goodwill 997,226 897,696
Other assets, net 175,698 179,463
Total assets 14,577,522 13,872,995
Liabilities and shareholders' deficit    
Accounts payable 6,359,619 6,091,700
Self-insurance reserves 123,505 128,548
Accrued payroll 141,361 138,122
Accrued benefits and withholdings 201,351 174,650
Income taxes payable 206,776 7,860
Current portion of operating lease liabilities 408,571 389,536
Other current liabilities 743,982 730,937
Total current liabilities 8,185,165 7,661,353
Long-term debt 5,359,810 5,570,125
Operating lease liabilities, less current portion 1,938,162 1,881,344
Deferred income taxes 325,869 295,471
Other liabilities 207,580 203,980
Shareholders' (equity) deficit:    
Common stock, $0.01 par value: Authorized shares - 245,000,000 Issued and outstanding shares - 57,838,920 as of September 30, 2024, and 59,072,792 as of December 31, 2023 578 591
Additional paid-in capital 1,449,447 1,352,275
Retained deficit (2,875,955) (3,131,532)
Accumulated other comprehensive (loss) income (13,134) 39,388
Total shareholders' deficit (1,439,064) (1,739,278)
Total liabilities and shareholders' deficit $ 14,577,522 $ 13,872,995
[1] The balance sheet at December 31, 2023, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by United States generally accepted accounting principles for complete financial statements.
v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2024
Dec. 31, 2023
Condensed Consolidated Balance Sheets    
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 245,000,000 245,000,000
Common stock, shares issued 57,838,920 59,072,792
Common stock, shares outstanding 57,838,920 59,072,792
v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Condensed Consolidated Statements of Income        
Sales $ 4,364,437 $ 4,203,380 $ 12,612,878 $ 11,980,235
Cost of goods sold, including warehouse and distribution expenses 2,113,212 2,042,917 6,159,421 5,842,861
Gross profit 2,251,225 2,160,463 6,453,457 6,137,374
Selling, general and administrative expenses 1,354,497 1,263,241 3,940,950 3,669,734
Operating income 896,728 897,222 2,512,507 2,467,640
Other income (expense):        
Interest expense (55,166) (51,361) (167,145) (145,520)
Interest income 2,055 1,292 5,239 2,920
Other, net 4,304 (486) 9,266 8,179
Total other expense (48,807) (50,555) (152,640) (134,421)
Income before income taxes 847,921 846,667 2,359,867 2,333,219
Provision for income taxes 182,457 196,840 524,317 539,142
Net income $ 665,464 $ 649,827 $ 1,835,550 $ 1,794,077
Earnings per share-basic:        
Earnings per share $ 11.47 $ 10.82 $ 31.34 $ 29.46
Weighted-average common shares outstanding - basic 57,998 60,082 58,563 60,905
Earnings per share-assuming dilution:        
Earnings per share $ 11.41 $ 10.72 $ 31.14 $ 29.20
Weighted-average common shares outstanding - assuming dilution 58,335 60,590 58,942 61,445
v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Condensed Consolidated Statements of Comprehensive Income        
Net Income (Loss) $ 665,464 $ 649,827 $ 1,835,550 $ 1,794,077
Other comprehensive income (loss):        
Foreign currency translation adjustments (22,026) (5,782) (52,522) 27,293
Total other comprehensive income (loss) (22,026) (5,782) (52,522) 27,293
Comprehensive income $ 643,438 $ 644,045 $ 1,783,028 $ 1,821,370
v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common stock [Member]
Additional paid-in capital [Member]
Retained earnings (deficit) [Member]
Accumulated other comprehensive income (loss) [Member]
Total
Balance at beginning of period at Dec. 31, 2022 $ 624 $ 1,311,488 $ (2,375,860) $ 2,996 $ (1,060,752)
Balance (in shares) at Dec. 31, 2022 62,353,000        
Net Income (Loss)     1,794,077   1,794,077
Other comprehensive income (loss)       27,293 27,293
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes   16,649     16,649
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes, shares 22,000        
Net issuance of common stock upon exercise of stock options $ 2 56,483     56,485
Net issuance of common stock upon exercise of stock options, shares 207,000        
Share-based compensation   20,555     20,555
Share repurchases, including fees $ (30) (64,012) (2,526,938)   $ (2,590,980)
Share repurchases, including fees, shares (2,961,000)       (2,961,000)
Excise tax on net share repurchases     (23,796)   $ (23,796)
Balance at end of period at Sep. 30, 2023 $ 596 1,341,163 (3,132,517) 30,289 (1,760,469)
Balance (in shares) at Sep. 30, 2023 59,621,000        
Balance at beginning of period at Jun. 30, 2023 $ 604 1,330,270 (2,994,418) 36,071 (1,627,473)
Balance (in shares) at Jun. 30, 2023 60,402,000        
Net Income (Loss)     649,827   649,827
Other comprehensive income (loss)       (5,782) (5,782)
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes   5,239     5,239
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes, shares 7,000        
Net issuance of common stock upon exercise of stock options $ 1 17,685     17,686
Net issuance of common stock upon exercise of stock options, shares 64,000        
Share-based compensation   6,900     6,900
Share repurchases, including fees $ (9) (18,931) (780,589)   $ (799,529)
Share repurchases, including fees, shares (852,000)       (852,000)
Excise tax on net share repurchases     (7,337)   $ (7,337)
Balance at end of period at Sep. 30, 2023 $ 596 1,341,163 (3,132,517) 30,289 (1,760,469)
Balance (in shares) at Sep. 30, 2023 59,621,000        
Balance at beginning of period at Dec. 31, 2023 $ 591 1,352,275 (3,131,532) 39,388 $ (1,739,278) [1]
Balance (in shares) at Dec. 31, 2023 59,073,000       59,072,792
Net Income (Loss)     1,835,550   $ 1,835,550
Other comprehensive income (loss)       (52,522) (52,522)
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes   18,213     18,213
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes, shares 20,000        
Net issuance of common stock upon exercise of stock options $ 3 96,043     96,046
Net issuance of common stock upon exercise of stock options, shares 291,000        
Share-based compensation   20,138     20,138
Share repurchases, including fees $ (16) (37,222) (1,567,271)   $ (1,604,509)
Share repurchases, including fees, shares (1,545,000)       (1,545,000)
Excise tax on net share repurchases     (12,702)   $ (12,702)
Balance at end of period at Sep. 30, 2024 $ 578 1,449,447 (2,875,955) (13,134) $ (1,439,064)
Balance (in shares) at Sep. 30, 2024 57,839,000       57,838,920
Balance at beginning of period at Jun. 30, 2024 $ 582 1,415,799 (3,008,665) 8,892 $ (1,583,392)
Balance (in shares) at Jun. 30, 2024 58,239,000        
Net Income (Loss)     665,464   665,464
Other comprehensive income (loss)       (22,026) (22,026)
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes   5,809     5,809
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes, shares 6,000        
Net issuance of common stock upon exercise of stock options $ 1 33,225     33,226
Net issuance of common stock upon exercise of stock options, shares 92,000        
Share-based compensation   6,865     6,865
Share repurchases, including fees $ (5) (12,251) (528,462)   $ (540,718)
Share repurchases, including fees, shares (498,000)       (498,000)
Excise tax on net share repurchases     4,292   $ 4,292
Balance at end of period at Sep. 30, 2024 $ 578 $ 1,449,447 $ (2,875,955) $ (13,134) $ (1,439,064)
Balance (in shares) at Sep. 30, 2024 57,839,000       57,838,920
[1] The balance sheet at December 31, 2023, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by United States generally accepted accounting principles for complete financial statements.
v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating activities:    
Net Income (Loss) $ 1,835,550 $ 1,794,077
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization of property, equipment and intangibles 339,324 296,583
Amortization of debt discount and issuance costs 4,870 3,597
Deferred income taxes 8,536 35,982
Share-based compensation programs 21,600 21,948
Other 5,928 3,574
Changes in operating assets and liabilities:    
Accounts receivable (9,175) (58,658)
Inventory (212,491) (263,896)
Accounts payable 252,454 315,910
Income taxes payable 198,780 353,366
Other (20,287) 15,172
Net cash provided by operating activities 2,425,089 2,517,655
Investing activities:    
Purchases of property and equipment (732,916) (753,958)
Proceeds from sale of property and equipment 10,268 10,461
Investment in tax credit equity investments 0 (4,150)
Other (160,960) (2,126)
Net cash used in investing activities (883,608) (749,773)
Financing activities:    
Proceeds from borrowings on revolving credit facility 30,000 3,227,000
Payments on revolving credit facility (30,000) (3,227,000)
Net (payments) proceeds of commercial paper (706,850) 1,025,075
Proceeds from the issuance of long-term debt 498,910 0
Principal payments on long-term debt 0 (300,000)
Payment of debt issuance costs (3,900) (39)
Repurchases of common stock (1,604,509) (2,590,980)
Net proceeds from issuance of common stock 112,825 71,604
Other (569) (354)
Net cash used in financing activities (1,704,093) (1,794,694)
Effect of exchange rate changes on cash (907) 893
Net decrease in cash and cash equivalents (163,519) (25,919)
Cash and cash equivalents at beginning of the period 279,132 108,583
Cash and cash equivalents at end of the period 115,613 82,664
Supplemental disclosures of cash flow information:    
Income taxes paid 419,331 147,128
Interest paid, net of capitalized interest $ 139,228 $ 127,085
v3.24.3
BASIS OF PRESENTATION
 9 Months Ended
Sep. 30, 2024
Basis of Presentation  
Basis of presentation

NOTE 1 – BASIS OF PRESENTATION

​

The accompanying unaudited condensed consolidated financial statements of O’Reilly Automotive, Inc. and its subsidiaries (the “Company” or “O’Reilly”) have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.  Operating results for the three and nine months ended September 30, 2024, are not necessarily indicative of the results that may be expected for the year ended December 31, 2024.  For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2023.

​

Principles of consolidation:

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All inter-company balances and transactions have been eliminated in consolidation.    
v3.24.3
Business Combination
 9 Months Ended
Sep. 30, 2024
Business Combination  
Business combination

NOTE 2 – BUSINESS COMBINATION

​

On January 22, 2024, the Company completed the previously announced strategic acquisition of Groupe Del Vasto (“Vast Auto”), an auto parts supplier headquartered in Montreal, Quebec, Canada, pursuant to a stock purchase agreement whereby 100% of all outstanding shares of Vast Auto were acquired, with all consideration paid in cash at closing.  The acquisition of Vast Auto represents O’Reilly’s entrance into the Canadian automotive aftermarket.  At the time of the acquisition, Vast Auto operated two distribution centers and six satellite warehouses that support a network of 23 company-owned stores and thousands of independent jobber and professional customers across Eastern Canada.  The results of Vast Auto’s operations have been included in the Company’s condensed consolidated financial statements beginning from the date of acquisition.  Pro forma results of operations related to the acquisition of Vast Auto are not presented as Vast Auto’s results are not material to the Company’s results of operations.

​

The purchase price allocation process, which is still ongoing, consists of collecting data and information to enable the Company to value the assets acquired and liabilities assumed as a result of the business combination.  The Company has substantially completed purchase price allocations related to working capital, including inventory, accounts receivable, accounts payable, and property, plant, and equipment.  Potential identifiable intangible assets that continue to be evaluated include, but are not limited to, trade names and trademarks, non-compete agreements, and customer relationships.  In addition, other assets, including internal use software, and other assumed liabilities may be identified, valued, and recorded.  The Company has engaged a third-party valuation specialist to assist with the valuation of the intangible assets.  This process is ongoing and the Company remains in the initial measurement period.

​

The preliminary purchase price allocation remains provisional and will change as additional information is obtained and valuation work is completed during the initial measurement period.  The Company’s preliminary assessment resulted in the initial recognition of $109.8 million of goodwill and intangible assets, which has been increased by $0.4 million during the initial measurement period, including impacts from the recognition of applicable deferred taxes related to the acquisition, which is included in “Goodwill” on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024.  Goodwill generated from this acquisition is not amortizable for tax purposes.
v3.24.3
VARIABLE INTEREST ENTITIES
 9 Months Ended
Sep. 30, 2024
Variable Interest Entities  
Variable interest entities

NOTE 3 – VARIABLE INTEREST ENTITIES

​

The Company has invested in certain tax credit funds that promote renewable energy.  These investments generate a return primarily through the realization of federal tax credits and other tax benefits.  The Company accounts for the tax attributes of its renewable energy investments using the deferral method.  Under this method, realized investment tax credits and other tax benefits are recognized as a reduction of the renewable energy tax credits.

​

The Company has determined its investment in these tax credit funds were investments in variable interest entities (“VIEs”).  The Company analyzes any investments in VIEs at inception and again if certain triggering events are identified to determine if it is the primary beneficiary.  The Company considers a variety of factors in identifying the entity that holds the power to direct matters that most significantly impact the VIEs’ economic performance including, but not limited to, the ability to direct financing, leasing, construction, and other operating decisions and activities.  As of September 30, 2024, the Company had invested in six unconsolidated tax credit fund entities that were considered to be VIEs and concluded it was not the primary beneficiary of any of the entities, as it did

not have the power to control the activities that most significantly impact the entities, and has therefore accounted for these investments using the equity method.  

​

The Company’s maximum exposure to losses associated with these VIEs is generally limited to its net investment, which was $28.4 million as of September 30, 2024, and was included in “Other assets, net” on the accompanying Condensed Consolidated Balance Sheets.  

v3.24.3
FAIR VALUE MEASUREMENTS
 9 Months Ended
Sep. 30, 2024
Fair Value Measurements  
Fair value measurements

NOTE 4 – FAIR VALUE MEASUREMENTS

​

The Company uses the fair value hierarchy, which prioritizes the inputs used to measure the fair value of certain of its financial instruments.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  The Company uses the income and market approaches to determine the fair value of its assets and liabilities.  The three levels of the fair value hierarchy are set forth below:

●Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.
●Level 2 – Inputs other than quoted prices in active markets included within Level 1 that are observable for the asset or liability, either directly or indirectly.
●Level 3 – Unobservable inputs for the asset or liability.

​

Financial assets and liabilities measured at fair value on a recurring basis:

The Company invests in various marketable securities with the intention of selling these securities to fulfill its future unsecured obligations under the Company’s nonqualified deferred compensation plan.  See Note 12 for further information concerning the Company’s benefit plans.

​

The Company’s marketable securities were accounted for as trading securities and the carrying amount of its marketable securities were included in “Other assets, net” on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024, and December 31, 2023.  The Company recorded an increase in fair value related to its marketable securities in the amount of $3.3 million and a decrease in fair value related to its marketable securities in the amount of $1.4 million for the three months ended September 30, 2024 and 2023, respectively, which were included in “Other income (expense)” on the accompanying Condensed Consolidated Statements of Income.  The Company recorded an increase in fair value related to its marketable securities in the amount of $7.4 million and $3.6 million for the nine months ended September 30, 2024 and 2023, respectively, which were included in “Other income (expense)” on the accompanying Condensed Consolidated Statements of Income.

​

The tables below identify the estimated fair value of the Company’s marketable securities, determined by reference to quoted market prices (Level 1), as of September 30, 2024, and December 31, 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 30, 2024

​

​

Quoted Priced in Active Markets

​

Significant Other

​

Significant

​

​

​

​

​

for Identical Instruments

​

Observable Inputs

​

Unobservable Inputs

​

​

​

​

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Total

Marketable securities

​

$

65,677

​

$

—

​

$

—

​

$

65,677

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2023

​

​

Quoted Prices in Active Markets

​

Significant Other

​

Significant

​

​

​

​

for Identical Instruments

​

Observable Inputs

​

Unobservable Inputs

​

​

​

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Total

Marketable securities

​

$

59,508

​

$

—

​

$

—

​

$

59,508

​

Non-financial assets and liabilities measured at fair value on a nonrecurring basis:

Certain long-lived non-financial assets and liabilities may be required to be measured at fair value on a nonrecurring basis in certain circumstances, including when there is evidence of impairment.  These non-financial assets and liabilities may include assets acquired in a business combination or property and equipment that are determined to be impaired.  As of September 30, 2024, and December 31, 2023, the Company did not have any non-financial assets or liabilities that had been measured at fair value subsequent to initial recognition.

​

Fair value of financial instruments:

The carrying amounts of the Company’s senior notes, unsecured revolving credit facility borrowings, and commercial paper program borrowings are included in “Long-term debt” on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024, and December 31, 2023.  

​

The table below identifies the estimated fair value of the Company’s senior notes, using the market approach.  The fair value as of September 30, 2024, and December 31, 2023, was determined by reference to quoted market prices of the same or similar instruments (Level 2) (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 30, 2024

​

December 31, 2023

​

​

Carrying Amount

​

Estimated Fair Value

​

Carrying Amount

​

Estimated Fair Value

Senior Notes

​

$

5,319,844

​

$

5,268,906

​

$

4,820,543

​

$

4,687,065

​

The carrying amount of the Company’s unsecured revolving credit facility approximates fair value (Level 2), as borrowings under the facility bear variable interest at current market rates.  The carrying amount of the Company’s commercial paper program approximates fair value (Level 2), as borrowings under the program bear interest at market rates prevailing at the time of issuance.  See Note 7 for further information concerning the Company’s senior notes, unsecured revolving credit facility, and commercial paper program.

​

The accompanying Condensed Consolidated Balance Sheets include other financial instruments, including cash and cash equivalents, accounts receivable, amounts receivable from suppliers, and accounts payable.  Due to the short-term nature of these financial instruments, the Company believes that the carrying values of these instruments approximate their fair values.
v3.24.3
LEASES
 9 Months Ended
Sep. 30, 2024
Leases  
Leases

NOTE 5 – LEASES

​

The Company leases certain office space, retail stores, distribution centers, and equipment under long-term, non-cancelable operating leases.  The following table summarizes Total lease cost for the three and nine months ended September 30, 2024 and 2023, which were primarily included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

​

2023

    

2024

​

2023

Operating lease cost

​

$

107,146

​

$

100,559

​

$

315,741

​

$

296,624

Short-term operating lease cost

​

 

1,965

​

 

1,708

​

 

6,375

​

 

7,213

Variable operating lease cost

​

 

29,386

​

 

25,696

​

 

84,565

​

 

75,257

Sublease income

​

 

(1,315)

​

 

(1,143)

​

 

(3,681)

​

 

(3,632)

Total lease cost

​

$

137,182

​

$

126,820

​

$

403,000

​

$

375,462

​

The following table summarizes other lease-related information for the nine months ended September 30, 2024 and 2023:

​

​

​

​

​

​

​

​

​

​

    

For the Nine Months Ended

​

​

September 30, 

​

​

2024

​

2023

Cash paid for amounts included in the measurement of operating lease liabilities:

 

​

  

​

​

​

​

Operating cash flows from operating leases

​

$

309,572

​

$

291,033

Right-of-use assets obtained in exchange for new operating lease liabilities

​

​

291,486

​

​

324,893

​
v3.24.3
SUPPLIER FINANCE PROGRAMS
 9 Months Ended
Sep. 30, 2024
Supplier Finance Programs  
Supplier Finance Programs

NOTE 6 – SUPPLIER FINANCE PROGRAM

​

The Company has established and maintains supplier finance programs with certain third-party financial institutions, which allow participating merchandise suppliers to voluntarily elect to assign the Company’s payment obligations due to these merchandise suppliers to one of the designated third-party institutions.  Under these supplier finance programs, the Company has agreed to pay the third-party financial institutions the stated amount of confirmed merchandise supplier invoices on the original maturity dates of the invoices, which are generally for a term of one year.  The Company does not have any assets pledged as security or other forms of guarantees for the committed payment to the third-party financial institutions.  As of September 30, 2024, and December 31, 2023, the Company had obligations outstanding under these programs for invoices that were confirmed as valid to the third-party financial institutions in the amounts of $4.5 billion and $4.4 billion, respectively, which were included as a component of “Accounts payable” on the accompanying Condensed Consolidated Balance Sheets.
v3.24.3
FINANCING
 9 Months Ended
Sep. 30, 2024
Financing  
Financing

NOTE 7 – FINANCING

​

The following table identifies the amounts included in “Long-term debt” on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024, and December 31, 2023 (in thousands):

​

​

​

​

​

​

​

​

​

    

September 30, 2024

    

December 31, 2023

Commercial paper program, weighted-average variable interest rate of 4.980% as of September 30, 2024 and 5.640% as of December 31, 2023

​

​

40,000

​

​

750,900

3.550% Senior Notes due 2026, effective interest rate of 3.570%

​

 

500,000

​

 

500,000

5.750% Senior Notes due 2026, effective interest rate of 5.767%

​

​

750,000

​

​

750,000

3.600% Senior Notes due 2027, effective interest rate of 3.619%

​

 

750,000

​

 

750,000

4.350% Senior Notes due 2028, effective interest rate of 4.383%

​

 

500,000

​

 

500,000

3.900% Senior Notes due 2029, effective interest rate of 3.901%

​

​

500,000

​

​

500,000

4.200% Senior Notes due 2030, effective interest rate of 4.205%

​

​

500,000

​

​

500,000

1.750% Senior Notes due 2031, effective interest rate of 1.798%

​

​

500,000

​

​

500,000

4.700% Senior Notes due 2032, effective interest rate of 4.740%

​

​

850,000

​

​

850,000

5.000% Senior Notes due 2034, effective interest rate of 5.028%

​

​

500,000

​

​

—

Total principal amount of debt

​

​

5,390,000

​

​

5,600,900

Less: Unamortized discount and debt issuance costs

​

​

30,190

​

​

30,775

Total long-term debt

​

$

5,359,810

​

$

5,570,125

​

Unsecured revolving credit facility:

The Company is party to a credit agreement dated June 15, 2021, as amended as of March 6, 2023 (the “Credit Agreement”).  The Credit Agreement provides for a five-year $1.8 billion unsecured revolving credit facility (the “Revolving Credit Facility”) arranged by JPMorgan Chase Bank, N.A., which is scheduled to mature in June of 2026.  The Credit Agreement includes a $200 million sub-limit for the issuance of letters of credit and a $75 million sub-limit for swing line borrowings under the Revolving Credit Facility.  As described in the Credit Agreement governing the Revolving Credit Facility, the Company may, from time to time, subject to certain conditions, increase the aggregate commitments under the Revolving Credit Facility by up to $900 million, provided that the aggregate amount of the commitments does not exceed $2.7 billion at any time.

​

As of September 30, 2024, and December 31, 2023, the Company had outstanding letters of credit, primarily to support obligations related to workers’ compensation, general liability, and other insurance policies, under the Credit Agreement each in the amount of $5.4 million, reducing the aggregate availability under the Credit Agreement by those amounts.  Substantially all of these outstanding letters of credit have a one-year term from the date of issuance.  As of September 30, 2024, and December 31, 2023, the Company had no outstanding borrowings under its Revolving Credit Facility.  

​

Borrowings under the Revolving Credit Facility (other than swing line loans) bear interest, at the Company’s option, at either an Alternate Base Rate or an Adjusted Term SOFR Rate (both as defined in the Credit Agreement) plus an applicable margin.  Swing line loans made under the Revolving Credit Facility bear interest at an Alternate Base Rate plus the applicable margin for Alternate Base Rate loans.  In addition, the Company pays a facility fee on the aggregate amount of the commitments under the Credit Agreement in an amount equal to a percentage of such commitments.  The interest rate margins and facility fee are based upon the better of the ratings assigned to the Company’s debt by Moody’s Investor Service, Inc. and Standard & Poor’s Ratings Services, subject to limited exceptions.  As of September 30, 2024, based upon the Company’s current credit ratings, its margin for Alternate Base Rate loans was 0.000%, its margin for Term Benchmark Revolving Loans was 0.900%, and its facility fee was 0.100%.

​

The Credit Agreement contains certain covenants, including limitations on subsidiary indebtedness, a minimum consolidated fixed charge coverage ratio of 2.50:1.00 and a maximum consolidated leverage ratio of 3.50:1.00.  The consolidated fixed charge coverage ratio includes a calculation of earnings before interest, taxes, depreciation, amortization, rent, and non-cash share-based compensation expense to fixed charges.  Fixed charges include interest expense, capitalized interest, and rent expense.  The consolidated leverage ratio includes a calculation of adjusted debt to earnings before interest, taxes, depreciation, amortization, rent, and non-cash share-based compensation expense.  Adjusted debt includes outstanding debt, outstanding stand-by letters of credit, and similar instruments, five-times rent expense and excludes any premium or discount recorded in conjunction with the issuance of long-term debt.  In the event that the Company should default on any covenant (subject to customary grace periods, cure rights, and materiality thresholds) contained in the Credit Agreement, certain actions may be taken, including, but not limited to, possible termination of commitments, immediate payment of outstanding principal amounts plus accrued interest and other amounts payable under the Credit Agreement, and litigation from lenders.  As of September 30, 2024, the Company remained in compliance with all covenants under the Credit Agreement.

​

In addition to the letters of credit issued under the Credit Agreement described above, as of September 30, 2024, and December 31, 2023, the Company had additional outstanding letters of credit, primarily to support obligations under workers’ compensation, general liability,

and other insurance policies, in the amount of $121.9 million and $106.8 million, respectively.  Substantially all of these letters of credit have a one-year term from the date of issuance and were not issued under the Company’s Credit Agreement or another committed facility.

​

Commercial paper program:

On August 9, 2023, the Company established a commercial paper program (the “Program”) pursuant to which it may issue short-term, unsecured commercial paper notes (the “Notes”) under the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.  Amounts available under the Program may be borrowed, repaid, and re-borrowed from time to time, with the aggregate face or principal amount of the Notes outstanding under the Program at any time not to exceed $1.8 billion.  The Notes will have maturities of up to 397 days from the date of issue.  The Notes rank at least pari passu with all of the Company’s other unsecured and unsubordinated indebtedness.  The Company plans to use its Revolving Credit Facility as a liquidity backstop for the repayment of Notes outstanding under the Program.  The Notes issued under the Program were included in “Long-term debt” on the accompanying Condensed Consolidated Balance Sheet as of September 30, 2024, as the Company has the ability and intent to refinance these Notes on a long-term basis.

​

Senior notes:

On August 19, 2024, the Company issued $500 million aggregate principal amount of unsecured 5.000% Senior Notes due 2034 (“5.000% Senior Notes due 2034”) at a price to the public of 99.782% of their face value with U.S. Bank Trust Company, National Association (“U.S. Bank”) as trustee.  Interest on the 5.000% Senior Notes due 2034 is payable on August 19 and February 19 of each year, beginning on February 19, 2025, and is computed on the basis of a 360-day year.

​

As of September 30, 2024, the Company has issued and outstanding a cumulative $5.4 billion aggregate principal amount of unsecured senior notes, which are due between 2026 and 2034, with UMB Bank, N.A. and U.S. Bank Trust Company, National Association as trustees.  Interest on the senior notes, ranging from 1.750% to 5.750%, is payable semi-annually and is computed on the basis of a 360-day year.  None of the Company’s subsidiaries is a guarantor under the senior notes.  Each of the senior notes is subject to certain customary covenants, with which the Company complied as of September 30, 2024.        

v3.24.3
WARRANTIES
 9 Months Ended
Sep. 30, 2024
Warranties  
Warranties

NOTE 8 – WARRANTIES

​

The Company provides warranties on certain merchandise it sells with warranty periods ranging from 30 days to limited lifetime warranties. The risk of loss arising from warranty claims is typically the obligation of the Company’s suppliers. Certain suppliers provide upfront allowances to the Company in lieu of accepting the obligation for warranty claims.  For this merchandise, when sold, the Company bears the risk of loss associated with the cost of warranty claims.  Differences between supplier allowances received by the Company, in lieu of warranty obligations and estimated warranty expense, are recorded as an adjustment to cost of sales.  Estimated warranty costs, which are recorded as obligations at the time of sale, are based on the historical failure rate of each individual product line.  The Company’s historical experience has been that failure rates are relatively consistent over time and that the ultimate cost of warranty claims to the Company has been driven by volume of units sold as opposed to fluctuations in failure rates or the variation of the cost of individual claims.

​

The Company’s product warranty liabilities are included in “Other current liabilities” on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024, and December 31, 2023; the following table identifies the changes in the Company’s aggregate product warranty liabilities for the nine months ended September 30, 2024 (in thousands):

​

​

​

​

​

Warranty liabilities, balance at December 31, 2023

​

$

117,895

Warranty claims

​

 

(151,873)

Warranty accruals

​

 

166,195

Foreign currency translation

​

​

(79)

Warranty liabilities, balance at September 30, 2024

​

$

132,138

​
v3.24.3
SHARE REPURCHASE PROGRAM
 9 Months Ended
Sep. 30, 2024
Share Repurchase Program  
Share repurchase program

NOTE 9 – SHARE REPURCHASE PROGRAM

​

In January of 2011, the Company’s Board of Directors approved a share repurchase program. Under the program, the Company may, from time to time, repurchase shares of its common stock, solely through open market purchases effected through a broker dealer at prevailing market prices, based on a variety of factors such as price, corporate trading policy requirements, and overall market conditions.  The Company’s Board of Directors may increase or otherwise modify, renew, suspend, or terminate the share repurchase program at any time, without prior notice.  As announced on May 23, 2023, and November 16, 2023, the Company’s Board of Directors each time approved a resolution to increase the authorization amount under the share repurchase program by an additional $2.0 billion, resulting in a cumulative authorization amount of $25.8 billion.  The additional authorizations are effective for three years, beginning on their respective announcement date.

​

The following table identifies shares of the Company’s common stock that have been repurchased as part of the Company’s publicly announced share repurchase program for the three and nine months ended September 30, 2024 and 2023 (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Shares repurchased

 

​

498

​

​

852

 

​

1,545

​

​

2,961

Average price per share

​

$

1,084.28

​

$

938.11

​

$

1,038.32

​

$

874.99

Total investment

​

$

540,713

​

$

799,520

​

$

1,604,494

​

$

2,590,950

​

As of September 30, 2024, the Company had $967.7 million remaining under its share repurchase authorization.  Excise tax on shares repurchased, assessed at one percent of the fair market value of shares repurchased, was $16.0 million for the nine months ended September 30, 2024.

​

Subsequent to the end of the third quarter and through November 8, 2024, the Company repurchased 0.2 million additional shares of its common stock under its share repurchase program, at an average price of $1,174.84, for a total investment of $192.4 million.  The Company has repurchased a total of 95.8 million shares of its common stock under its share repurchase program since the inception of the program in January of 2011 and through November 8, 2024, at an average price of $260.71, for a total aggregate investment of $25.0 billion.

v3.24.3
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
 9 Months Ended
Sep. 30, 2024
Accumulated Other Comprehensive Income (Loss)  
Accumulated Other Comprehensive Income (Loss)

NOTE 10 – ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

​

Accumulated other comprehensive income (loss) includes adjustments for foreign currency translations. The tables below summarize activity for changes in accumulated other comprehensive income (loss) for the three and nine months ended September 30, 2024 and 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Loss

Accumulated other comprehensive income, balance at June 30, 2024

​

$

8,892

​

$

8,892

Change in accumulated other comprehensive loss

​

​

(22,026)

​

​

(22,026)

Accumulated other comprehensive loss, balance at September 30, 2024

​

$

(13,134)

​

$

(13,134)

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Loss

Accumulated other comprehensive income, balance at December 31, 2023

​

$

39,388

​

$

39,388

Change in accumulated other comprehensive loss

​

​

(52,522)

​

​

(52,522)

Accumulated other comprehensive loss, balance at September 30, 2024

​

$

(13,134)

​

$

(13,134)

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Income

Accumulated other comprehensive income, balance at June 30, 2023

​

$

36,071

​

$

36,071

Change in accumulated other comprehensive loss

​

​

(5,782)

​

​

(5,782)

Accumulated other comprehensive income, balance at September 30, 2023

​

$

30,289

​

$

30,289

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Income

Accumulated other comprehensive income, balance at December 31, 2022

​

$

2,996

​

$

2,996

Change in accumulated other comprehensive income

​

​

27,293

​

​

27,293

Accumulated other comprehensive income, balance at September 30, 2023

​

$

30,289

​

$

30,289

(1)Foreign currency translation is not shown net of additional U.S. tax, as other basis differences of non-U.S. subsidiaries are intended to be permanently reinvested.
v3.24.3
REVENUE
 9 Months Ended
Sep. 30, 2024
Revenue  
Revenue

NOTE 11 – REVENUE

​

The table below identifies the Company’s revenues disaggregated by major customer type for the three and nine months ended September 30, 2024 and 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Sales to do-it-yourself customers

​

$

2,215,640

​

$

2,206,511

​

$

6,366,670

​

$

6,254,980

Sales to professional service provider customers

 

​

2,032,376

 

​

1,914,884

 

​

5,901,820

 

​

5,480,212

Other sales, sales adjustments, and sales from the acquired Vast Auto stores

 

​

116,421

 

​

81,985

 

​

344,388

 

​

245,043

Total sales

​

$

4,364,437

​

$

4,203,380

​

$

12,612,878

​

$

11,980,235

​

See Note 8 for information concerning the expected costs associated with the Company’s assurance warranty obligations.  See Note 2 for information concerning the recent acquisition of Vast Auto.

v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS
 9 Months Ended
Sep. 30, 2024
Share-Based Compensation and Benefit Plans  
Share-based compensation and benefit plans

NOTE 12 – SHARE-BASED COMPENSATION AND BENEFIT PLANS

​

The Company recognizes share-based compensation expense based on the fair value of the grants, awards, or shares at the time of the grant, award, or issuance.  Share-based compensation includes stock option awards, restricted stock awards, and stock appreciation rights issued under the Company’s incentive plans and stock issued through the Company’s employee stock purchase plan.

​

Stock options:

The Company’s incentive plans provide for the granting of stock options for the purchase of common stock of the Company to certain key employees of the Company.  Employee stock options are granted at an exercise price that is equal to the closing market price of the Company’s common stock on the date of the grant.  Employee stock options granted under the plans expire after 10 years and typically vest 25% per year, over four years.  The Company records compensation expense for the grant date fair value of the option awards evenly over the vesting period or minimum required service period.

​

The table below identifies stock option activity under these plans during the nine months ended September 30, 2024 (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

Shares

​

Weighted- Average

​

​

(in thousands)

​

Exercise Price

Outstanding at December 31, 2023

 

884

​

$

428.50

Granted

 

70

​

 

1,061.73

Exercised

 

(291)

​

 

329.59

Forfeited or expired

 

(9)

​

 

676.68

Outstanding at September 30, 2024

 

654

​

$

537.18

Exercisable at September 30, 2024

 

443

​

$

393.93

​

The fair value of each stock option award is estimated on the date of the grant using the Black-Scholes option pricing model. The Black-Scholes model requires the use of assumptions, including the risk-free rate, expected life, expected volatility, and expected dividend yield.

●Risk-free interest rate – The United States Treasury rates in effect at the time the options are granted for the options’ expected life.
●Expected life – Represents the period of time that options granted are expected to be outstanding. The Company uses historical experience to estimate the expected life of options granted.
●Expected volatility – Measure of the amount, by which the Company’s stock price is expected to fluctuate, based on a historical trend.
●Expected dividend yield – The Company has not paid, nor does it have plans in the foreseeable future to pay, any dividends.

​

The table below identifies the weighted-average assumptions used for grants awarded during the nine months ended September 30, 2024 and 2023:

​

​

​

​

​

​

​

​

​

​

September 30, 

​

    

2024

​

2023

Risk free interest rate

 

4.18

%  

​

3.92

%  

Expected life

 

6.4

Years

​

6.3

Years

Expected volatility

 

28.2

%  

​

29.0

%  

Expected dividend yield

 

—

%  

​

—

%  

​

The following table summarizes activity related to stock options awarded by the Company for the three and nine months ended September 30, 2024 and 2023 (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

​

2023

Compensation expense for stock options awarded

​

$

5,838

​

$

5,977

​

$

17,175

​

$

17,892

Income tax benefit from compensation expense related to stock options

​

 

1,480

​

 

1,476

​

 

4,355

​

 

4,417

​

The weighted-average grant-date fair value of options granted during the nine months ended September 30, 2024, was $403.77, compared to $321.36 for the nine months ended September 30, 2023.  The remaining unrecognized compensation expense related to unvested stock option awards at September 30, 2024, was $48.7 million, and the weighted-average period of time over which this cost will be recognized is 2.8 years.

​

Other share-based compensation plans:

The Company sponsors other share-based compensation plans:  an employee stock purchase plan and incentive plans that provide for the awarding of shares of restricted stock to certain key employees and directors.  The Company’s employee stock purchase plan (the “ESPP”) permits eligible employees to purchase shares of the Company’s common stock at 85% of the fair market value.  The fair value of shares issued under the ESPP is based on the average of the high and low market prices of the Company’s common stock during the offering periods, and compensation expense is recognized based on the discount between the fair value and the employee purchase price for the shares sold to employees.  Restricted stock awarded under the incentive plans to certain key employees and directors vests after one-year or evenly over a three-year period and is held in escrow until such vesting has occurred.  The fair value of shares awarded under the incentive plans is based on the closing market price of the Company’s common stock on the date of the award, and compensation expense is recorded evenly over the vesting period or the minimum required service period.

​

The table below summarizes activity related to the Company’s other share-based compensation plans for the three and nine months ended September 30, 2024 and 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Compensation expense for shares issued under the ESPP

​

$

1,027

​

$

923

​

$

2,963

​

$

2,663

Income tax benefit from compensation expense related to shares issued under the ESPP

​

​

260

​

​

228

​

​

751

​

​

657

Compensation expense for restricted shares awarded

​

​

506

​

​

477

​

​

1,462

​

​

1,393

Income tax benefit from compensation expense related to restricted awards

​

$

128

​

$

118

​

$

371

​

$

344

​

Profit sharing and savings plan:

The Company sponsors a contributory profit sharing and savings plan (the “401(k) Plan”) that covers substantially all employees who are at least 21 years of age.  The Company makes matching contributions equal to 100% of the first 2% of each employee’s wages that are contributed and 25% of the next 4% of each employee’s wages that are contributed.  The Company may also make additional discretionary profit sharing contributions to the 401(k) Plan on an annual basis as determined by the Board of Directors.  The Company did not make any discretionary contributions to the 401(k) Plan during the nine months ended September 30, 2024 or 2023.  The Company expensed matching contributions under the 401(k) Plan in the amount of $14.0 million and $13.4 million for the three months ended September 30, 2024 and 2023, respectively, which were primarily included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.  The Company expensed matching contributions under the 401(k) Plan in the amount of $40.6 million and $35.9 million for the nine months ended September 30, 2024 and 2023, respectively, which

were primarily included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.  

​

Nonqualified deferred compensation plan:

The Company sponsors a nonqualified deferred compensation plan (the “Deferred Compensation Plan”) for highly compensated employees whose contributions to the 401(k) Plan are limited due to the application of the annual limitations under the Internal Revenue Code, which could then be matched by the Company using the same formula as the 401(k) plan.  In the event of bankruptcy, the assets of this plan are available to satisfy the claims of general creditors.  The Company has an unsecured obligation to pay, in the future, the value of the deferred compensation and Company match, if applicable, adjusted to reflect the performance, whether positive or negative, of selected investment measurement options chosen by each participant during the deferral period.  See Note 4 for further information concerning the Company’s marketable securities held to fulfill our future unsecured obligations under this plan.

​

The liability for compensation deferred under the Deferred Compensation Plan was $65.7 million and $59.5 million as of September 30, 2024, and December 31, 2023, respectively, which was included in “Other liabilities” on the accompanying Condensed Consolidated Balance Sheets.  The Company expensed contributions under the Deferred Compensation Plan in the amount of less than $0.1 million for each of the three months ended September 30, 2024 and 2023, which were included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.  The Company expensed matching contributions under the Deferred Compensation Plan in the amount of $0.1 million and less than $0.1 million for the nine months ended September 30, 2024 and 2023, respectively, which were included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.      

​

Stock appreciation rights:

The Company’s incentive plans provide for the granting of stock appreciation rights, which expire after 10 years and vest 25% per year, over four years, and are settled in cash.  As of September 30, 2024, and December 31, 2023, there were 15,044 and 13,079 stock appreciation rights outstanding, respectively.  During the nine months ended September 30, 2024, there were 2,491 stock appreciation rights granted, 350 stock appreciation rights exercised, and 176 stock appreciation rights forfeited.  The liability for compensation to be paid for redeemed stock appreciation rights was $6.7 million and $4.5 million as of September 30, 2024, and December 31, 2023, respectively, which were included in “Other liabilities” on the Condensed Consolidated Balance Sheets.  The Company recorded compensation expense for stock appreciation rights in the amount of $1.4 million and compensation benefit for stock appreciation rights in the amount of $0.1 million for the three months ended September 30, 2024 and 2023, respectively, which were included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.  The Company recorded compensation expense for stock appreciation rights in the amount of $3.1 million and $0.6 million for the nine months ended September 30, 2024 and 2023, respectively, which were included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income.

v3.24.3
COMMITMENTS
 9 Months Ended
Sep. 30, 2024
Commitments  
Commitments

NOTE 13 – COMMITMENTS

​

The Company has a conditional agreement to purchase federal renewable energy tax credits (“RETC”).  As of September 30, 2024, the Company had a remaining commitment to purchase approximately $200 million RETCs, with the final closing payment anticipated to occur by June of 2025.

v3.24.3
EARNINGS PER SHARE
 9 Months Ended
Sep. 30, 2024
Earnings Per Share  
Earnings per share

NOTE 14 – EARNINGS PER SHARE

​

The following table illustrates the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2024 and 2023 (in thousands, except per share data):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Numerator (basic and diluted):

 

​

  

 

​

  

 

​

  

 

​

  

Net income

​

$

665,464

​

$

649,827

​

$

1,835,550

​

$

1,794,077

​

​

​

​

​

​

​

​

​

​

​

​

​

Denominator:

​

 

  

​

 

  

​

 

  

​

 

  

Weighted-average common shares outstanding – basic

​

 

57,998

​

 

60,082

​

 

58,563

​

 

60,905

Effect of stock options (1)

​

 

337

​

 

508

​

 

379

​

 

540

Weighted-average common shares outstanding – assuming dilution

​

 

58,335

​

 

60,590

​

 

58,942

​

 

61,445

​

​

​

​

​

​

​

​

​

​

​

​

​

Earnings per share:

​

 

  

​

 

  

​

 

  

​

 

  

Earnings per share-basic

​

$

11.47

​

$

10.82

​

$

31.34

​

$

29.46

Earnings per share-assuming dilution

​

$

11.41

​

$

10.72

​

$

31.14

​

$

29.20

​

​

​

​

​

​

​

​

​

​

​

​

​

Antidilutive potential common shares not included in the calculation of diluted earnings per share:

​

 

  

​

 

  

​

 

  

​

 

  

Stock options (1)

​

 

92

​

 

83

​

 

115

​

 

98

Weighted-average exercise price per share of antidilutive stock options (1)

​

$

1,026.97

​

$

853.21

​

$

977.48

​

$

824.23

(1)See Note 12 for further information concerning the terms of the Company’s share-based compensation plans.

​

For the three and nine months ended September 30, 2024 and 2023, the computation of diluted earnings per share did not include certain securities. These securities represent underlying stock options not included in the computation of diluted earnings per share, because the inclusion of such equity awards would have been antidilutive.

​

See Note 9 for information concerning the Company’s subsequent share repurchases.  
v3.24.3
LEGAL MATTERS
 9 Months Ended
Sep. 30, 2024
Legal Matters  
Legal matters

NOTE 15 – LEGAL MATTERS

​

The Company is currently involved in litigation incidental to the ordinary conduct of the Company’s business.  Based on existing facts and historical patterns, the Company accrues for litigation losses in instances where an adverse outcome is probable and the Company is able to reasonably estimate the probable loss in accordance with Accounting Standard Codification 450-20.  The Company also accrues for an estimate of legal costs to be incurred for litigation matters.  Although the Company cannot ascertain the amount of liability that it may incur from legal matters, it does not currently believe that, in the aggregate, these matters, taking into account applicable insurance and accruals, will have a material adverse effect on its consolidated financial position, results of operations or cash flows in a particular quarter or annual period.  
v3.24.3
RECENT ACCOUNTING PRONOUNCEMENTS
 9 Months Ended
Sep. 30, 2024
Recent Accounting Pronouncements  
Recent accounting pronouncements

NOTE 16 – RECENT ACCOUNTING PRONOUNCEMENTS

​

In November of 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standard Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”).  ASU 2023-07 increases the disclosures about a public entity’s reportable segments.  Under ASU 2023-07, a public entity would be required to disclose significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), a description of other segment items by reportable segment, annual disclosures about a reportable segment’s profit or loss and assets required by Topic 280 in interim periods, any additional measures of a segment’s profit or loss used by the CODM to allocate resources, and the title and position of the CODM.  ASU 2023-07 is effective for annual reporting periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024.  ASU 2023-07 allows for early adoption and requires retrospective adoption.  The Company will adopt this guidance beginning with its fourth quarter ending December 31, 2024.  The application of this new guidance is not expected to have a material impact on the Company’s consolidated financial condition, results of operations, or cash flows, as the guidance pertains to disclosure only.

​

In December of 2023, FASB issued Accounting Standard Update ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”).  Under ASU 2023-09, a public entity will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold, such as if the effect of the reconciling item is equal to or greater than five percent of the amount computed by multiplying pretax income/loss by the applicable statutory income tax rate.  Entities would also have to disclose the amount of income taxes paid disaggregated by federal, state, and foreign taxes and the amount of income taxes paid disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than five percent of total income taxes paid, along with income/loss from continuing operations before income tax expense disaggregated between domestic and foreign and income tax expense from continuing operations disaggregated by federal, state, and foreign.  ASU 2023-09 is effective for annual reporting periods beginning after December 15, 2024.  ASU 2023-09 allows for early adoption for annual financial statements that have not yet been issued and allows retrospective and prospective adoption.  The Company will adopt this guidance beginning with its fourth quarter ending December 31, 2025.  The application of this new guidance is not expected to have a material impact on the Company’s consolidated financial condition, results of operations, or cash flows, as the guidance pertains to disclosure only.

​

In November of 2024, FASB issued Accounting Standard Update ASU No. 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”).  Under 2024-03, a public entity would be required to disclose information about purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depletion for each income statement line item that contains those expenses.  Entities would also have to disclose other specific expenses, gains, or losses that are already required to be disclosed under GAAP in this same disclosure, a qualitative description of the amounts remaining that are not separately disaggregated quantitatively, and the total amount of selling expenses, as well as an entity’s definition of selling expenses.  ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027.  ASU 2024-03 allows for early adoption and requires either prospective adoption to financial statements issued for reporting periods after the effective date of ASU 2024-03 or retrospectively to any or all prior periods presented in the financial statements.  The Company will adopt this guidance beginning with its fourth quarter ending December 31, 2027.  The application of this new guidance is not expected to have a material impact on the Company’s consolidated financial condition, results of operations, or cash flows, as the guidance pertains to disclosure only.  
v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure        
Net Income (Loss) $ 665,464 $ 649,827 $ 1,835,550 $ 1,794,077
v3.24.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.3
BASIS OF PRESENTATION (Policies)
 9 Months Ended
Sep. 30, 2024
Basis of Presentation.  
Principles of consolidation, policy

Principles of consolidation:

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All inter-company balances and transactions have been eliminated in consolidation.    
v3.24.3
VARIABLE INTEREST ENTITIES (Policies)
 9 Months Ended
Sep. 30, 2024
Variable Interest Entities  
Variable interest entities, policy

The Company has invested in certain tax credit funds that promote renewable energy.  These investments generate a return primarily through the realization of federal tax credits and other tax benefits.  The Company accounts for the tax attributes of its renewable energy investments using the deferral method.  Under this method, realized investment tax credits and other tax benefits are recognized as a reduction of the renewable energy tax credits.

​

The Company has determined its investment in these tax credit funds were investments in variable interest entities (“VIEs”).  The Company analyzes any investments in VIEs at inception and again if certain triggering events are identified to determine if it is the primary beneficiary.  The Company considers a variety of factors in identifying the entity that holds the power to direct matters that most significantly impact the VIEs’ economic performance including, but not limited to, the ability to direct financing, leasing, construction, and other operating decisions and activities.  As of September 30, 2024, the Company had invested in six unconsolidated tax credit fund entities that were considered to be VIEs and concluded it was not the primary beneficiary of any of the entities, as it did

not have the power to control the activities that most significantly impact the entities, and has therefore accounted for these investments using the equity method.  

​

The Company’s maximum exposure to losses associated with these VIEs is generally limited to its net investment, which was $28.4 million as of September 30, 2024, and was included in “Other assets, net” on the accompanying Condensed Consolidated Balance Sheets.  

v3.24.3
FAIR VALUE MEASUREMENTS (Policies)
 9 Months Ended
Sep. 30, 2024
Fair Value Measurements  
Fair value of financial instruments

​

The Company uses the fair value hierarchy, which prioritizes the inputs used to measure the fair value of certain of its financial instruments.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  The Company uses the income and market approaches to determine the fair value of its assets and liabilities.  The three levels of the fair value hierarchy are set forth below:

●Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.
●Level 2 – Inputs other than quoted prices in active markets included within Level 1 that are observable for the asset or liability, either directly or indirectly.
●Level 3 – Unobservable inputs for the asset or liability.
v3.24.3
WARRANTIES (Policies)
 9 Months Ended
Sep. 30, 2024
Warranties  
Warranties, policy

The Company provides warranties on certain merchandise it sells with warranty periods ranging from 30 days to limited lifetime warranties. The risk of loss arising from warranty claims is typically the obligation of the Company’s suppliers. Certain suppliers provide upfront allowances to the Company in lieu of accepting the obligation for warranty claims.  For this merchandise, when sold, the Company bears the risk of loss associated with the cost of warranty claims.  Differences between supplier allowances received by the Company, in lieu of warranty obligations and estimated warranty expense, are recorded as an adjustment to cost of sales.  Estimated warranty costs, which are recorded as obligations at the time of sale, are based on the historical failure rate of each individual product line.  The Company’s historical experience has been that failure rates are relatively consistent over time and that the ultimate cost of warranty claims to the Company has been driven by volume of units sold as opposed to fluctuations in failure rates or the variation of the cost of individual claims.
v3.24.3
FAIR VALUE MEASUREMENTS (Tables)
 9 Months Ended
Sep. 30, 2024
Fair Value Measurements  
Valuation of marketable securities

The tables below identify the estimated fair value of the Company’s marketable securities, determined by reference to quoted market prices (Level 1), as of September 30, 2024, and December 31, 2023 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 30, 2024

​

​

Quoted Priced in Active Markets

​

Significant Other

​

Significant

​

​

​

​

​

for Identical Instruments

​

Observable Inputs

​

Unobservable Inputs

​

​

​

​

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Total

Marketable securities

​

$

65,677

​

$

—

​

$

—

​

$

65,677

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2023

​

​

Quoted Prices in Active Markets

​

Significant Other

​

Significant

​

​

​

​

for Identical Instruments

​

Observable Inputs

​

Unobservable Inputs

​

​

​

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Total

Marketable securities

​

$

59,508

​

$

—

​

$

—

​

$

59,508
Valuation of senior notes

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 30, 2024

​

December 31, 2023

​

​

Carrying Amount

​

Estimated Fair Value

​

Carrying Amount

​

Estimated Fair Value

Senior Notes

​

$

5,319,844

​

$

5,268,906

​

$

4,820,543

​

$

4,687,065
v3.24.3
LEASES (Tables)
 9 Months Ended
Sep. 30, 2024
Leases  
Summary of total lease cost

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

​

2023

    

2024

​

2023

Operating lease cost

​

$

107,146

​

$

100,559

​

$

315,741

​

$

296,624

Short-term operating lease cost

​

 

1,965

​

 

1,708

​

 

6,375

​

 

7,213

Variable operating lease cost

​

 

29,386

​

 

25,696

​

 

84,565

​

 

75,257

Sublease income

​

 

(1,315)

​

 

(1,143)

​

 

(3,681)

​

 

(3,632)

Total lease cost

​

$

137,182

​

$

126,820

​

$

403,000

​

$

375,462
Other lease related information

​

​

​

​

​

​

​

​

​

​

    

For the Nine Months Ended

​

​

September 30, 

​

​

2024

​

2023

Cash paid for amounts included in the measurement of operating lease liabilities:

 

​

  

​

​

​

​

Operating cash flows from operating leases

​

$

309,572

​

$

291,033

Right-of-use assets obtained in exchange for new operating lease liabilities

​

​

291,486

​

​

324,893

​
v3.24.3
FINANCING (Tables)
 9 Months Ended
Sep. 30, 2024
Financing  
Outstanding financing facilities

​

​

​

​

​

​

​

​

​

    

September 30, 2024

    

December 31, 2023

Commercial paper program, weighted-average variable interest rate of 4.980% as of September 30, 2024 and 5.640% as of December 31, 2023

​

​

40,000

​

​

750,900

3.550% Senior Notes due 2026, effective interest rate of 3.570%

​

 

500,000

​

 

500,000

5.750% Senior Notes due 2026, effective interest rate of 5.767%

​

​

750,000

​

​

750,000

3.600% Senior Notes due 2027, effective interest rate of 3.619%

​

 

750,000

​

 

750,000

4.350% Senior Notes due 2028, effective interest rate of 4.383%

​

 

500,000

​

 

500,000

3.900% Senior Notes due 2029, effective interest rate of 3.901%

​

​

500,000

​

​

500,000

4.200% Senior Notes due 2030, effective interest rate of 4.205%

​

​

500,000

​

​

500,000

1.750% Senior Notes due 2031, effective interest rate of 1.798%

​

​

500,000

​

​

500,000

4.700% Senior Notes due 2032, effective interest rate of 4.740%

​

​

850,000

​

​

850,000

5.000% Senior Notes due 2034, effective interest rate of 5.028%

​

​

500,000

​

​

—

Total principal amount of debt

​

​

5,390,000

​

​

5,600,900

Less: Unamortized discount and debt issuance costs

​

​

30,190

​

​

30,775

Total long-term debt

​

$

5,359,810

​

$

5,570,125
v3.24.3
WARRANTIES (Tables)
 9 Months Ended
Sep. 30, 2024
Warranties  
Changes in product warranty liabilities

​

​

​

​

​

Warranty liabilities, balance at December 31, 2023

​

$

117,895

Warranty claims

​

 

(151,873)

Warranty accruals

​

 

166,195

Foreign currency translation

​

​

(79)

Warranty liabilities, balance at September 30, 2024

​

$

132,138

​
v3.24.3
SHARE REPURCHASE PROGRAM (Tables)
 9 Months Ended
Sep. 30, 2024
Share Repurchase Program  
Schedule of shares repurchased

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Shares repurchased

 

​

498

​

​

852

 

​

1,545

​

​

2,961

Average price per share

​

$

1,084.28

​

$

938.11

​

$

1,038.32

​

$

874.99

Total investment

​

$

540,713

​

$

799,520

​

$

1,604,494

​

$

2,590,950
v3.24.3
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)
 9 Months Ended
Sep. 30, 2024
Accumulated Other Comprehensive Income (Loss)  
Summary of activity for changes in accumulated other comprehensive income (loss)

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Loss

Accumulated other comprehensive income, balance at June 30, 2024

​

$

8,892

​

$

8,892

Change in accumulated other comprehensive loss

​

​

(22,026)

​

​

(22,026)

Accumulated other comprehensive loss, balance at September 30, 2024

​

$

(13,134)

​

$

(13,134)

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Loss

Accumulated other comprehensive income, balance at December 31, 2023

​

$

39,388

​

$

39,388

Change in accumulated other comprehensive loss

​

​

(52,522)

​

​

(52,522)

Accumulated other comprehensive loss, balance at September 30, 2024

​

$

(13,134)

​

$

(13,134)

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Income

Accumulated other comprehensive income, balance at June 30, 2023

​

$

36,071

​

$

36,071

Change in accumulated other comprehensive loss

​

​

(5,782)

​

​

(5,782)

Accumulated other comprehensive income, balance at September 30, 2023

​

$

30,289

​

$

30,289

​

​

​

​

​

​

​

​

​

​

Foreign

​

Total Accumulated Other

​

​

Currency (1)

​

Comprehensive Income

Accumulated other comprehensive income, balance at December 31, 2022

​

$

2,996

​

$

2,996

Change in accumulated other comprehensive income

​

​

27,293

​

​

27,293

Accumulated other comprehensive income, balance at September 30, 2023

​

$

30,289

​

$

30,289

(1)Foreign currency translation is not shown net of additional U.S. tax, as other basis differences of non-U.S. subsidiaries are intended to be permanently reinvested.
v3.24.3
REVENUE (Tables)
 9 Months Ended
Sep. 30, 2024
Revenue  
Disaggregation of revenue

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Sales to do-it-yourself customers

​

$

2,215,640

​

$

2,206,511

​

$

6,366,670

​

$

6,254,980

Sales to professional service provider customers

 

​

2,032,376

 

​

1,914,884

 

​

5,901,820

 

​

5,480,212

Other sales, sales adjustments, and sales from the acquired Vast Auto stores

 

​

116,421

 

​

81,985

 

​

344,388

 

​

245,043

Total sales

​

$

4,364,437

​

$

4,203,380

​

$

12,612,878

​

$

11,980,235
v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS (Tables)
 9 Months Ended
Sep. 30, 2024
Employee Stock Option [Member]  
Share-Based Compensation and Benefit Plans  
Summary of stock options

​

​

​

​

​

​

​

​

​

Shares

​

Weighted- Average

​

​

(in thousands)

​

Exercise Price

Outstanding at December 31, 2023

 

884

​

$

428.50

Granted

 

70

​

 

1,061.73

Exercised

 

(291)

​

 

329.59

Forfeited or expired

 

(9)

​

 

676.68

Outstanding at September 30, 2024

 

654

​

$

537.18

Exercisable at September 30, 2024

 

443

​

$

393.93
Black-Scholes option pricing model

​

​

​

​

​

​

​

​

​

​

September 30, 

​

    

2024

​

2023

Risk free interest rate

 

4.18

%  

​

3.92

%  

Expected life

 

6.4

Years

​

6.3

Years

Expected volatility

 

28.2

%  

​

29.0

%  

Expected dividend yield

 

—

%  

​

—

%  
Summary of activity of share-based compensation and benefit plans

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

​

2023

Compensation expense for stock options awarded

​

$

5,838

​

$

5,977

​

$

17,175

​

$

17,892

Income tax benefit from compensation expense related to stock options

​

 

1,480

​

 

1,476

​

 

4,355

​

 

4,417
Employee stock purchase plan [Member] | Restricted stock [Member]  
Share-Based Compensation and Benefit Plans  
Summary of activity of share-based compensation and benefit plans

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Compensation expense for shares issued under the ESPP

​

$

1,027

​

$

923

​

$

2,963

​

$

2,663

Income tax benefit from compensation expense related to shares issued under the ESPP

​

​

260

​

​

228

​

​

751

​

​

657

Compensation expense for restricted shares awarded

​

​

506

​

​

477

​

​

1,462

​

​

1,393

Income tax benefit from compensation expense related to restricted awards

​

$

128

​

$

118

​

$

371

​

$

344
v3.24.3
EARNINGS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2024
Earnings Per Share  
Computation of basic and diluted earnings per share

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

    

2024

    

2023

Numerator (basic and diluted):

 

​

  

 

​

  

 

​

  

 

​

  

Net income

​

$

665,464

​

$

649,827

​

$

1,835,550

​

$

1,794,077

​

​

​

​

​

​

​

​

​

​

​

​

​

Denominator:

​

 

  

​

 

  

​

 

  

​

 

  

Weighted-average common shares outstanding – basic

​

 

57,998

​

 

60,082

​

 

58,563

​

 

60,905

Effect of stock options (1)

​

 

337

​

 

508

​

 

379

​

 

540

Weighted-average common shares outstanding – assuming dilution

​

 

58,335

​

 

60,590

​

 

58,942

​

 

61,445

​

​

​

​

​

​

​

​

​

​

​

​

​

Earnings per share:

​

 

  

​

 

  

​

 

  

​

 

  

Earnings per share-basic

​

$

11.47

​

$

10.82

​

$

31.34

​

$

29.46

Earnings per share-assuming dilution

​

$

11.41

​

$

10.72

​

$

31.14

​

$

29.20

​

​

​

​

​

​

​

​

​

​

​

​

​

Antidilutive potential common shares not included in the calculation of diluted earnings per share:

​

 

  

​

 

  

​

 

  

​

 

  

Stock options (1)

​

 

92

​

 

83

​

 

115

​

 

98

Weighted-average exercise price per share of antidilutive stock options (1)

​

$

1,026.97

​

$

853.21

​

$

977.48

​

$

824.23

(1)See Note 12 for further information concerning the terms of the Company’s share-based compensation plans.

​
v3.24.3
Business Combination (Narrative) (Details) - Groupe Del Vasto [Member]
$ in Millions
Sep. 30, 2024
USD ($)
Jan. 22, 2024
item
Business Combination    
Business Acquisition, Percentage of Voting Interests Acquired   100.00%
Number of distribution centers   2
Number of satellite warehouses   6
Number of stores   23
Increase in provisional goodwill and intangibles acquired | $ $ 0.4  
Goodwill [Member]    
Business Combination    
Initial provisional goodwill and intangibles acquired | $ $ 109.8  
v3.24.3
VARIABLE INTEREST ENTITIES (Narrative) (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2024
USD ($)
entity
Variable Interest Entities  
Number of unconsolidated tax credit fund entities that were considered to be Variable Interest Entities | entity 6
Equity method investment in VIEs, net | $ $ 28.4
v3.24.3
FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Fair Value Measurements          
Increase (decrease) in fair value of marketable securities $ 3.3 $ (1.4) $ 7.4 $ 3.6  
Non-financial assets and liabilities measured at fair value on a nonrecurring basis $ 0.0   $ 0.0   $ 0.0
v3.24.3
FAIR VALUE MEASUREMENTS (Fair Value of Marketable Securities) (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Fair Value Measurements    
Estimated fair value of marketable securities $ 65,677 $ 59,508
Fair value, inputs, Level 1 [Member]    
Fair Value Measurements    
Estimated fair value of marketable securities $ 65,677 $ 59,508
v3.24.3
FAIR VALUE MEASUREMENTS (Fair Value of Senior Notes) (Details) - Fair value, inputs, Level 2 [Member] - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Fair Value Measurements    
Carrying amount of senior notes $ 5,319,844 $ 4,820,543
Estimated fair value of senior notes $ 5,268,906 $ 4,687,065
v3.24.3
LEASES (Summary of Total Lease Cost) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Leases        
Operating lease cost $ 107,146 $ 100,559 $ 315,741 $ 296,624
Short-term operating lease cost 1,965 1,708 6,375 7,213
Variable operating lease cost 29,386 25,696 84,565 75,257
Sublease income (1,315) (1,143) (3,681) (3,632)
Total lease cost $ 137,182 $ 126,820 $ 403,000 $ 375,462
v3.24.3
LEASES (Supplemental Cash Flow Information) (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Leases    
Cash paid for amounts included in the measurement of operating lease liabilities, operating cash flows from operating leases $ 309,572 $ 291,033
Right-of-use asset obtained in exchange for new operating lease liability $ 291,486 $ 324,893
v3.24.3
SUPPLIER FINANCE PROGRAMS (Details) - Supplier Finance Programs [Member] - USD ($)
$ in Billions
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Debt instrument term 1 year 1 year
Assets pledged as security or other forms of guarantees $ 0.0 $ 0.0
Accounts payable, trade $ 4.5 $ 4.4
v3.24.3
FINANCING (Unsecured Revolving Credit Facility) (Narrative) (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Unsecured debt [Member] | Letter of credit [Member]    
Financing    
Number of years in debt instrument, term 1 year  
Letters of credit $ 121.9 $ 106.8
Line of credit facility [Member]    
Financing    
Unsecured revolving credit facility $ 0.0 0.0
Line of credit facility covenant compliance As of September 30, 2024, the Company remained in compliance with all covenants under the Credit Agreement.  
Line of credit facility [Member] | Unsecured debt [Member]    
Financing    
Credit agreement inception date Jun. 15, 2021  
Number of years in debt instrument, term 5 years  
Current maximum borrowing capacity under credit facility $ 1,800.0  
Maximum aggregate increase to credit facility allowable 900.0  
Maximum aggregate capacity of credit facility allowable $ 2,700.0  
Line of credit facility [Member] | Unsecured debt [Member] | Minimum [Member]    
Financing    
Consolidated fixed charge coverage ratio 2.50  
Line of credit facility [Member] | Unsecured debt [Member] | Maximum [Member]    
Financing    
Consolidated fixed charge coverage ratio 3.50  
Line of credit facility [Member] | Unsecured debt [Member] | Spread over Alternate Base rate [Member]    
Financing    
Line of credit current interest rate 0.00%  
Line of credit facility [Member] | Unsecured debt [Member] | Spread over Term Benchmark Revolving Loans rate [Member]    
Financing    
Line of credit current interest rate 0.90%  
Line of credit facility [Member] | Unsecured debt [Member] | Secured Overnight Financing Rate (SOFR) [Member]    
Financing    
Line of credit facility fee percentage 0.10%  
Line of credit facility [Member] | Unsecured debt [Member] | Letter of credit [Member]    
Financing    
Number of years in debt instrument, term 1 year  
Line of credit facility sublimit $ 200.0  
Letters of credit 5.4 $ 5.4
Line of credit facility [Member] | Unsecured debt [Member] | Swing line revolver [Member]    
Financing    
Line of credit facility sublimit $ 75.0  
v3.24.3
FINANCING (Commercial Paper Program) (Narrative) (Details) - Commercial Paper [Member]
$ in Billions
Sep. 30, 2024
USD ($)
Financing  
Number of years in debt instrument, term 397 days
Maximum [Member]  
Financing  
Current maximum borrowing capacity under credit facility $ 1.8
v3.24.3
FINANCING (Senior Notes) (Narrative) (Details)
$ in Thousands
 9 Months Ended
Aug. 19, 2024
USD ($)
D
Sep. 30, 2024
USD ($)
entity
D
Sep. 30, 2023
USD ($)
Financing      
Repayment of senior notes   $ 0 $ 300,000
Senior notes [Member]      
Financing      
Face amount of senior notes   $ 5,400,000  
Number of days in annual interest calculation period | D   360  
Number of guarantors under the senior notes | entity   0  
Debt instrument covenant compliance   Each of the senior notes is subject to certain customary covenants, with which the Company complied as of September 30, 2024.  
Minimum [Member] | Senior notes [Member]      
Financing      
Interest rate of senior notes   1.75%  
Maximum [Member] | Senior notes [Member]      
Financing      
Interest rate of senior notes   5.75%  
5.000% Senior Notes due 2034 [Member] | Senior notes [Member]      
Financing      
Issuance date of senior notes Aug. 19, 2024    
Face amount of senior notes $ 500,000 $ 500,000  
Interest rate of senior notes 5.00% 5.00%  
Percentage of face value of debt instrument 99.782%    
Number of days in annual interest calculation period | D 360    
v3.24.3
FINANCING (Outstanding Financing Facilities) (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Aug. 19, 2024
Dec. 31, 2023
Financing      
Total principal amount of debt $ 5,390,000   $ 5,600,900
Less: Unamortized discount and debt issuance costs 30,190   30,775
Total long-term debt 5,359,810   5,570,125 [1]
Commercial Paper [Member]      
Financing      
Debt instrument, principal amount $ 40,000   $ 750,900
Weighted-average variable interest rate 4.98%   5.64%
Senior notes [Member]      
Financing      
Debt instrument, principal amount $ 5,400,000    
Senior notes [Member] | 3.550% Senior Notes due 2026 [Member]      
Financing      
Debt instrument, principal amount $ 500,000   $ 500,000
Interest rate of senior notes 3.55%   3.55%
Senior notes, effective interest rate 3.57%   3.57%
Senior notes [Member] | 5.750% Senior Notes due 2026 [Member]      
Financing      
Debt instrument, principal amount $ 750,000   $ 750,000
Interest rate of senior notes 5.75%   5.75%
Senior notes, effective interest rate 5.767%   5.767%
Senior notes [Member] | 3.600% Senior Notes due 2027 [Member]      
Financing      
Debt instrument, principal amount $ 750,000   $ 750,000
Interest rate of senior notes 3.60%   3.60%
Senior notes, effective interest rate 3.619%   3.619%
Senior notes [Member] | 4.350% Senior Notes due 2028 [Member]      
Financing      
Debt instrument, principal amount $ 500,000   $ 500,000
Interest rate of senior notes 4.35%   4.35%
Senior notes, effective interest rate 4.383%   4.383%
Senior notes [Member] | 3.900% Senior Notes due 2029 [Member]      
Financing      
Debt instrument, principal amount $ 500,000   $ 500,000
Interest rate of senior notes 3.90%   3.90%
Senior notes, effective interest rate 3.901%   3.901%
Senior notes [Member] | 4.200% Senior Notes due 2030 [Member]      
Financing      
Debt instrument, principal amount $ 500,000   $ 500,000
Interest rate of senior notes 4.20%   4.20%
Senior notes, effective interest rate 4.205%   4.205%
Senior notes [Member] | 1.750% Senior Notes due 2031 [Member]      
Financing      
Debt instrument, principal amount $ 500,000   $ 500,000
Interest rate of senior notes 1.75%   1.75%
Senior notes, effective interest rate 1.798%   1.798%
Senior notes [Member] | 4.700% Senior Notes due 2032 [Member]      
Financing      
Debt instrument, principal amount $ 850,000   $ 850,000
Interest rate of senior notes 4.70%   4.70%
Senior notes, effective interest rate 4.74%   4.74%
Senior notes [Member] | 5.000% Senior Notes due 2034 [Member]      
Financing      
Debt instrument, principal amount $ 500,000 $ 500,000  
Interest rate of senior notes 5.00% 5.00%  
Senior notes, effective interest rate 5.028%    
[1] The balance sheet at December 31, 2023, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by United States generally accepted accounting principles for complete financial statements.
v3.24.3
WARRANTIES (Product Warranty Liabilities) (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
USD ($)
Warranties  
Warranty liabilities, beginning balance $ 117,895
Warranty claims (151,873)
Warranty accruals 166,195
Foreign currency translation (79)
Warranty liabilities, ending balance $ 132,138
v3.24.3
SHARE REPURCHASE PROGRAM (Narrative) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended 166 Months Ended
Nov. 16, 2023
May 23, 2023
Nov. 08, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Nov. 08, 2024
Share Repurchase Program [Line Items]                
Increase in authorized amount $ 2,000,000 $ 2,000,000            
Cumulative authorized amount $ 25,800,000              
Authorization effective period 3 years 3 years            
Remaining balance under share repurchase program       $ 967,700,000   $ 967,700,000    
Common stock repurchased, shares       498 852 1,545 2,961  
Common stock repurchased, average price per share       $ 1,084.28 $ 938.11 $ 1,038.32 $ 874.99  
Common stock repurchased, value       $ 540,713 $ 799,520 $ 1,604,494 $ 2,590,950  
Share repurchase program, excise tax           $ 16,000    
Subsequent event [Member]                
Share Repurchase Program [Line Items]                
Common stock repurchased, shares     200         95,800
Common stock repurchased, average price per share     $ 1,174.84         $ 260.71
Common stock repurchased, value     $ 192,400         $ 25,000,000
v3.24.3
SHARE REPURCHASE PROGRAM (Schedule of Shares Repurchased) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share Repurchase Program        
Shares repurchased 498 852 1,545 2,961
Average price per share $ 1,084.28 $ 938.11 $ 1,038.32 $ 874.99
Total investment $ 540,713 $ 799,520 $ 1,604,494 $ 2,590,950
v3.24.3
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Balance at beginning of period $ (1,583,392) $ (1,627,473) $ (1,739,278) [1] $ (1,060,752)
Change in accumulated other comprehensive income (loss) (22,026) (5,782) (52,522) 27,293
Balance at end of period (1,439,064) (1,760,469) (1,439,064) (1,760,469)
Accumulated other comprehensive income (loss) [Member]        
Balance at beginning of period 8,892 36,071 39,388 2,996
Change in accumulated other comprehensive income (loss) (22,026) (5,782) (52,522) 27,293
Balance at end of period (13,134) 30,289 (13,134) 30,289
Foreign currency [Member]        
Balance at beginning of period 8,892 36,071 39,388 2,996
Change in accumulated other comprehensive income (loss) (22,026) (5,782) (52,522) 27,293
Balance at end of period $ (13,134) $ 30,289 $ (13,134) $ 30,289
[1] The balance sheet at December 31, 2023, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by United States generally accepted accounting principles for complete financial statements.
v3.24.3
REVENUE (Disaggregation of Revenue) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue        
Sales $ 4,364,437 $ 4,203,380 $ 12,612,878 $ 11,980,235
DIY customer [Member]        
Disaggregation of Revenue        
Sales 2,215,640 2,206,511 6,366,670 6,254,980
Professional service provider customer [Member]        
Disaggregation of Revenue        
Sales 2,032,376 1,914,884 5,901,820 5,480,212
Other customers and sales adjustments [Member]        
Disaggregation of Revenue        
Sales $ 116,421 $ 81,985 $ 344,388 $ 245,043
v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS (Stock Option) (Narrative) (Details) - Stock option [Member] - USD ($)
$ / shares in Units, $ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Share-Based Compensation and Benefit Plans    
Weighted-average grant-date fair value of options awarded $ 403.77 $ 321.36
Remaining unrecognized compensation expense $ 48.7  
Weighted-average period for cost recognition 2 years 9 months 18 days  
Employee Stock Option [Member]    
Share-Based Compensation and Benefit Plans    
Options expiration period 10 years  
Vesting period 4 years  
Option vesting rate per year 25.00%  
v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS (Other Share-Based Compensation) (Narrative) (Details) - Employee stock purchase plan [Member]
 9 Months Ended
Sep. 30, 2024
Share-Based Compensation and Benefit Plans  
Employee stock purchase plan stock purchase percentage 85.00%
Restricted stock [Member] | Minimum [Member]  
Share-Based Compensation and Benefit Plans  
Vesting period 1 year
Restricted stock [Member] | Maximum [Member]  
Share-Based Compensation and Benefit Plans  
Vesting period 3 years
v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS (Profit Sharing and Savings Plan) (Narrative) (Detail) - Profit sharing and savings plan [Member] - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-Based Compensation and Benefit Plans        
Profit sharing and savings plan, employer discretionary contribution     $ 0 $ 0
Profit sharing and savings plan, cost recognized $ 14,000 $ 13,400 $ 40,600 $ 35,900
Employee's first 2% of contributed wages [Member]        
Share-Based Compensation and Benefit Plans        
Profit sharing and savings plan, Company match     100.00%  
Employee's next 4% of contributed wages [Member]        
Share-Based Compensation and Benefit Plans        
Profit sharing and savings plan, Company match     25.00%  
v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS (Nonqualified Deferred Compensation Plan) (Narrative) (Details) - Nonqualified Deferred Compensation Plan [Member] - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Share-Based Compensation and Benefit Plans          
Deferred compensation plan obligation $ 65.7   $ 65.7   $ 59.5
Deferred compensation plan cost recognized     $ 0.1    
Maximum [Member]          
Share-Based Compensation and Benefit Plans          
Deferred compensation plan cost recognized $ 0.1 $ 0.1   $ 0.1  
v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS (Stock Appreciation Rights) (Narrative) (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Share-Based Compensation and Benefit Plans          
Stock appreciation rights expiration period     10 years    
Stock appreciation rights vesting rate per year     25.00%    
Vesting period     4 years    
Stock appreciation rights outstanding 15,044   15,044   13,079
Stock appreciation rights granted during the period, units     2,491    
Stock appreciation rights exercised during the period, units     350    
Stock appreciation rights forfeited during the period, units     176    
Liability for compensation to be paid for redeemed stock appreciation rights $ 6.7   $ 6.7   $ 4.5
Compensation expense (benefit) for share-based compensation $ 1.4 $ (0.1) $ 3.1 $ 0.6  
v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS (Summary of Stock Options) (Details) - Employee Stock Option [Member] - $ / shares
shares in Thousands
 9 Months Ended
Sep. 30, 2024
Share-Based Compensation and Benefit Plans  
Outstanding shares, beginning balance 884
Outstanding weighted-average exercise price, beginning balance $ 428.50
Granted, shares 70
Granted, weighted-average exercise price $ 1,061.73
Exercised, shares (291)
Exercised, weighted-average exercise price $ 329.59
Forfeited or expired, shares (9)
Forfeited or expired, weighted-average exercise price $ 676.68
Outstanding shares, ending balance 654
Outstanding weighted-average exercise price, ending balance $ 537.18
Exercisable shares, ending balance 443
Exercisable weighted-average exercise price, ending balance $ 393.93
v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS (Black-Scholes Option Pricing Model) (Details) - Employee Stock Option
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Share-Based Compensation and Benefit Plans    
Risk-free interest rate 4.18% 3.92%
Expected life 6 years 4 months 24 days 6 years 3 months 18 days
Expected volatility 28.20% 29.00%
Expected dividend yield 0.00% 0.00%
v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS (Stock Option Activity) (Details) - Employee Stock Option [Member] - Stock option [Member] - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-Based Compensation and Benefit Plans        
Compensation expense (benefit) for share-based compensation $ 5,838 $ 5,977 $ 17,175 $ 17,892
Income tax benefit from compensation expense for share-based compensation $ 1,480 $ 1,476 $ 4,355 $ 4,417
v3.24.3
SHARE-BASED COMPENSATION AND BENEFIT PLANS (Other Share-Based Compensation Activity) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Employee stock purchase plan [Member]        
Share-Based Compensation and Benefit Plans        
Compensation expense (benefit) for share-based compensation $ 1,027 $ 923 $ 2,963 $ 2,663
Income tax benefit from compensation expense for share-based compensation 260 228 751 657
Restricted stock [Member]        
Share-Based Compensation and Benefit Plans        
Compensation expense (benefit) for share-based compensation 506 477 1,462 1,393
Income tax benefit from compensation expense for share-based compensation $ 128 $ 118 $ 371 $ 344
v3.24.3
COMMITMENTS (Commitments) (Narrative) (Details)
$ in Millions
Sep. 30, 2024
USD ($)
Commitments  
Purchase commitment $ 200
v3.24.3
EARNINGS PER SHARE (Computation of Basic and Diluted Earnings Per Share) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Numerator (basic and diluted):        
Net Income (Loss) $ 665,464 $ 649,827 $ 1,835,550 $ 1,794,077
Denominator:        
Denominator for basic earnings per share - weighted-average shares 57,998 60,082 58,563 60,905
Effect of stock options 337 508 379 540
Denominator for diluted earnings per share - weighted-average shares and assumed conversion 58,335 60,590 58,942 61,445
Earnings per share - basic $ 11.47 $ 10.82 $ 31.34 $ 29.46
Earnings per share - assuming dilution $ 11.41 $ 10.72 $ 31.14 $ 29.20
Antidilutive stock options 92 83 115 98
Weighted-average exercise price per share of antidilutive stock options $ 1,026.97 $ 853.21 $ 977.48 $ 824.23
O Reilly Automotive (NASDAQ:ORLY)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 O Reilly Automotive 차트를 더 보려면 여기를 클릭.
O Reilly Automotive (NASDAQ:ORLY)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 O Reilly Automotive 차트를 더 보려면 여기를 클릭.